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1. Abstract 
Reactive oxygen species (ROS) have been recognized to play important roles as messenger 
molecules. They are involved in the etiology and progression of cardiovascular diseases such as 
myocardial infarction, cardiac hypertrophy or fibrosis. Investigation of reactive oxygen species and 
cellular redox alterations has been methodologically challenging. Genetically encoded redox sensors 
make dynamic measurements of ROS and involved buffering systems in living cells possible. They can 
be targeted to specific cellular organelles and report compartment specific redox changes. Analysis 
of sensor response is performed by dual excitation single emission fluorescence microscopy or plate 
reader based assays. In the present study, we hypothesized that fluorescent redox sensors can be 
applied in human pluripotent stem cells and stem cell derived cardiomyocytes to investigate cell 
type and compartment specific differences in redox homeostasis. Genomic integration of two redox 
sensor systems was performed in human embryonic stem cells. Grx1-roGFP2 reacts and stays in 
equilibrium with cellular glutathione (GSH) pools, while HyPer can report increases in cellular 
hydrogen peroxide (H2O2). Grx1-roGFP2 was targeted to cytosol and mitochondria in transgenic stem 
cells to analyze their GSH balance in the two compartments. Stem cell mitochondria appeared to 
have a more oxidized GSH pool than the cytosol. Transgenic stem cell lines were also differentiated 
to cardiomyocytes, but failed to develop spontaneous beating activity. Due to this unexpected 
phenotype, a lentiviral integration approach was chosen to express Grx1-roGFP2 in cytosol and 
mitochondria of stem cell derived cardiomyocytes and primary dermal fibroblasts. While fibroblast 
GSH milieu appeared similar between cytosol and mitochondria, cardiomyocytes had strongly 
oxidized mitochondria compared to cytosol. As reactive oxygen species can be generated during 
oxidative phosphorylation in mitochondria, cellular metabolism might play an important role in the 
regulation of cellular redox homoeostasis. As a model of advanced maturation, stem cell derived 
cardiomyocytes were used to construct engineered heart muscle. Preliminary proof-of-concept for 
the analysis of redox sensors in this tissue model is reported in this study. To sense H2O2, we 
employed an alternative sensor, namely HyPer, which was able to report changes in intracellular 
H2O2 levels upon extracellular bolus addition of H2O2. Aside from detection of H2O2, also a sensor-
producer hybrid construct, HyperDAO, was deployed in a TSA model. Upon stimulation with D-
alanine, HyPerDAO produced H2O2 inside transgenic cells. Unfortunately, human embryonic stem 
cells transgenic for HyPer or HyPerDAO also failed to differentiate into beating cardiomyocytes. In 
summary, in this thesis tools for the analysis and manipulation of ROS and their buffering systems in 
a cell- and compartment-specific manner were developed. Further studies are needed to elucidate 
the mechanisms behind differences in cellular redox balances reported here and will lead to a 
deeper understanding of redox signaling in cardiac physiology and pathology.   
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 Introduction 2.
2.1. Reactive Oxygen Species and their role in the cardiovascular system 
Reactive Oxygen species (ROS) are characterized by free electron pairs and high reactivity. The 
superoxide anion, O2
.-, is derived from the reduction of molecular oxygen. Inside cells, it rapidly 
reacts with water to form hydrogen peroxide (H2O2), a strong and more stable oxidant. H2O2 
interacts with reactive protein residues and thereby alters overall protein conformation, function 
and stability. Among the possible modifications, the oxidation of cysteines is best studied. Accessible 
thiol groups are oxidized to form a sulfenic acid. If sulfenic acid is in proximity to another cysteine 
residue, an intra- or intermolecular disulfide can be formed, a very common form of protein activity 
regulation. It has been described for example that disulfide formation in the catalytic subunit of  
protein kinase A (PKA) can lead to protein dephosphorylation and kinase inactivation (Humphries et 
al., 2005). Disulfides can be reduced by cellular reductants such as the gluthathione (GSH) or 
thioredoxin (Trx) systems. Sulfenic acid can also form adducts with GSH leading to S-
glutathionylation of the target protein, another activity modulating post translational modification 
(Shackelford et al., 2005). If reactive nitrogen species such as nitric oxide (NO) are present, S-
nitrosylation of the sulfenic residue is also possible. Besides modulating protein activity as described 
for histone deacetylase 2 and PKA (Burgoyne & Eaton, 2009; Nott et al., 2008), nitrosylation might 
also be a protective mechanism preventing further oxidation of the thiol group. If sulfenic acid is 
oxidized further, sulfinic acid is formed. This modification can be reduced by sulfiredoxin (Biteau et 
al., 2003). Further oxidation yields sulfonic acid, a modification that is thought to be irreversible and 
is associated with protein inhibition by destruction of catalytic thiol groups. Similarly irreversible is 
the addition of carbonyl groups, including ketones and aldehydes that result from lipid peroxidation. 
Protein carbonylation is considered to lead to accumulation and enhanced degradation of targeted 
proteins (Wong et al., 2010). Possible targets of protein carbonylation include cysteine, lysine, 
arginine, proline and threonine.  
Other oxidized amino acids include methionine, tyrosine and tryptophan. Methionine oxidation 
yields a methionine sulfoxide that can be reduced through methionine sulfoxide reductase (MsrA) 
and plays a role in signaling, ROS scavenging, enzyme activity modulation and can target proteins for 
degradation (Stadtman et al., 2003). Activity modulation through methionine oxidation has been 
described for calcium-calmodulin dependent kinase II (CamKII), where an angiotensin 2 (Ang 2) 
induced oxidation of Met281/282 leads to kinase activation. This process might be relevant in 
cardiac pathology, as MsrA knock out mice show a more severe cardiac dysfunction with elevated 
CamKII oxidation after myocardial infarction (Erickson et al., 2008). Regarding tyrosine and 
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tryptophan oxidation, only little is known. Tyrosine forms dityronsines upon reaction with oxidants 
such as H2O2, whereas Tryptophan is mostly a target for nitration (Shao et al., 2012). 
In order to limit the accumulation and spread of oxidants as well as oxidative modifications, cells 
possess several defense mechanisms. Superoxide is detoxified by superoxide dismutates, which 
catalyze the reaction with water to H2O2. In turn, H2O2 can be degraded by catalases to water. The 
major cellular defense line against oxidative stress, however, is the glutathione system. 
Glutathionperoxidase (Gpx) oxidizes two GSH molecules to form the oxidized dimer GSSG for each 
reduction of H2O2. GSSG is then reduced to two GSH molecules through glutaredoxins (Grx) under 
the use of nicotinamide adenine dinucleotide phosphate (NADPH) as reduction equivalents (Figure 1 
A). Similarly, Trx can act as reduction equivalents for peroxiredoxins (Prx) and other proteins. They 
reduce disulfide bonds by formation of an intramolecular disulfide, which is in turn reduced by 
thioredoxin-reductase (TrxR) in an NADPH dependent reaction (Figure 1 B).  
 
Figure 1 The GSH and Trx antioxidant systems.A) Reduced Glutathione (GSH) acts as a redox equivalent for 
Glutaperoxidases (Gpx). Oxidized glutathione (GSSG) is reduced by Glutaredoxin (Grx) with NADPH as electron donor. B) 
Thioredoxin (Trx) is oxidized when recovering Peroxiredoxins (Prx). The intramolecular disulfide is removed by Thioredoxin-
reductates (TrxR).  
The cellular sources of ROS are manifold, but two dominant mechanisms have been described. One 
is the generation of superoxide in mitochondria due to electron transport chain leakage; the other is 
the generation of O2
.- and H2O2 by NADPH oxidases. 
In actively respiring mitochondria, electrons are transferred via the complexes I to IV in the inner 
mitochondrial membrane in order to establish a proton gradient for adenosine triphosphate (ATP) 
production. Leakage of electrons leading to the reduction of molecular oxygen to superoxide can 
occur at all stages, but is most common at complex I and III (Murphy, 2009). The generated 
superoxide is then degraded via mitochondrial superoxide dismutases to H2O2. Although a side 
product, mitochondrial ROS are implicated to act in redox signaling and via complex crosstalk 
mechanisms. They provide a feedback loop between electron transport chain and substrate 
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oxidation via the reaction with antioxidant NAD/NADH pools and can lead to so-called ROS induced 
ROS release into the cytosol (Zorov et al., 2000). This ROS induced ROS release can act as a 
pathologic amplifying mechanism in disease conditions, but has also been postulated to occur at 
baseline as a modulation of physiological ROS signaling and is then called superoxide flashes (Wang 
et al., 2008).  
NADPH oxidases (NOX) are heterodimeric flavocytochromes with a gp22phox subunit. Seven NOX 
subtypes have been characterized in total of which NOX2 and NOX4 are the main isoforms found in 
cardiomyocytes. They produce O2
.- and/or H2O2 at defined localizations within the cell, leading to 
local protein modifications. NOX2 is activated by association with regulatory subunits such as 
p47phox, p67phox, p40phox, and Rac1 and localized to the plasma membrane (Brandes et al., 2014).  
Activation occurs upon various stimuli via G-protein coupled receptor agonists, cytokines such as 
Ang 2 and mechanical stress and is related to apoptosis, interstitial fibrosis and hypertrophy (Bendall 
et al., 2002; Looi et al., 2008). In the physiological context, NOX2 derived H2O2 modulates Ca
2+ 
release by ryanodine receptor 2 (RyR2) and Ca2+ re-uptake through sarco/endoplasmic reticulum 
Ca2+ ATPase (SERCA) as well as myofilament function and ion channel activity through modulation of 
kinase pathways such as CamKII, PKA, and protein kinase G1a (Santos et al., 2016).   
NOX4 is thought to be constitutively active and its activity regulated by abundance and localization 
(Brandes et al., 2014). It is described to localize to perinuclear ER and mitochondria and plays a role 
in hypoxia, cardiac ischemia and pressure overload (Santos et al., 2016).  
Other ROS sources in cardiomyocytes include uncoupled NO synthases, xanthine oxidases (XO) and 
mitochondrial monoamino oxidases (MAO). Uncoupling of NO synthases occurs when the cofactor 
tetrahydrobiopterin (BH4) is depleted or by S-glutathionylation (Chen et al., 2010; Xia et al., 1998). 
As BH4 depletion is amplified by ROS, NOS uncoupling could be a further mechanism of potentiation 
of ROS signaling. As uncoupling can occur also partially, it leads to the concomitant production of 
superoxide and nitric oxide, which react to form peroxinitrite, ONOO-, leading to nitroxidative stress 
and protein nitration. XO catalyzes the oxidation of hypoxanthine to xanthine and further to uric 
acid. In this process, electrons are transferred to oxygen and water, generating O2
.- and H2O2. Heart 
failure seems to be associated with an upregulation of XO (de Jong et al., 2000). Furthermore, 
interactions of XO derived ROS with NO signaling have been implicated in RyR2 Ca2+ leak observed in 
heart failure (Gonzalez et al., 2010). Although pharmacological inhibition of XO has been beneficial in 
animal models (Naumova et al., 2006), large scale clinical trials did not report benefits of XO 
inhibition in patients with heart failure (Givertz et al., 2015). Recently, mitochondrial MAOs have 
been shown to play important roles in cardiovascular pathology (Deshwal et al., 2017). MAOs are 
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membrane bound enzymes in the outer mitochondrial membrane, which deaminate 
neurotransmitters and other amines. In these processes, H2O2 can be generated as a side product 
with an impact on mitochondria redox balance (Kaludercic et al., 2014).  
All the mechanisms described above contribute to the cellular redox homeostasis, which describes 
the balances between ROS production and antioxidant mechanisms. This balance is crucial for 
correct cardiomyocyte function. Disturbances in the regulation of oxidative and antioxidative 
balances have been shown to lead to cardiac dysfunction and disease. A cardiac pathology, where 
the involvement of ROS is well studied, is myocardial infarction. In myocardial infarction, arterial 
occlusion leads to a drop in perfusion and lack of oxygen supply to the affected tissue. As a 
consequence, mitochondrial respiration ceases and electrons that cannot be used for ATP synthesis 
accumulate. This leads to an increased production of ROS, which in turn can lead to opening of the 
mitochondrial permeability transition pore (mPTP) (Kim et al., 2006). The mPTP is a non-specific 
channel in the inner mitochondria membrane, which molecules up to 1.5 kDa can pass upon rapid 
opening. mPTP opening can lead to the release of Ca2+ and cytochrome c into the cytosol, which 
triggers cardiomyocyte dysfunction and apoptosis (Crompton, 1999). Furthermore, in ischemia 
energy production switches to glycolysis and ATP production rates decrease, leading to a decline in 
cellular energy levels. ATP reliant ion transporters such as Na+/K+ ATPase or SERCA are inhibited, 
leading to disturbances in cellular ion homeostasis characterized by an accumulation of intracellular 
Ca2+ (Paradis et al., 2016). Increased Ca2+ further stimulates mPTP opening, which releases more Ca2+ 
into the cytosol and leads to the hydrolysis of ATP by uncoupled F-ATPase, leading to an 
amplification of cellular damage.  
Reperfusion is crucial for cardiomyocyte survival, but initially leads to an amplification of damage. 
When circulation is re-established, the sudden availability of oxygen leads to a further increase in 
ROS, due to XO activity, impaired mitochondrial respiration and depleted antioxidant pools (Zhou et 
al., 2018). These ROS signals can further increase the mitochondrial damage via mPTP opening 
leading to mitochondrial swelling and rupture and thus activation of apoptotic pathways (Lesnefsky 
et al., 2017).  
Interestingly, reperfusion associated injury can be reduced by transient hypoxic episodes prior to 
prolonged ischemia. This phenomenon is termed ischemic preconditioning and has been strongly 
related to ROS signals. It is thought that the various pathways involved in this process converge on 
inhibition of mPTP opening, potentially by activation of protein kinase C through ROS derived from 
mitochondria and NOX2 (Yang et al., 2010). Furthermore, the beneficial effect of ischemic 
preconditioning can be observed for more than 24 hrs with the late phase mediated by an 
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upregulation of hypoxia inducible factor 1α (Hif1α) target genes such as inducible NO synthase or 
heme oxygenase-1 (Guo et al., 1999; Yoshida et al., 2001).  
Considering the important role of ROS in cardiovascular injury, the idea of ROS-scavenging therapies 
might seem appealing. Indeed, high plasma levels of antioxidant vitamins such as vitamin C, 
vitamin  E or polyphenols are often associated to reduce cardiovascular disease risk (Dauchet et al., 
2009). However, studies of dietary vitamin supplementation have failed to show clinical benefits in 
the prevention of cardiovascular disease (Myung et al., 2013). In addition, therapeutic approaches 
“flooding” the organism with antioxidants do not make sense in light of physiologic roles of ROS 
signaling, which is required for proper cardiomyocyte function. Nonetheless there is data from small 
scale clinical trials using antioxidant administration before angioplasty in patients with myocardial 
infarction. The rationale behind these approaches is the prevention of reperfusion injury by 
prevention of ROS bursts upon re-oxygenation of the infarcted tissue. In this context ascorbate 
infusion was shown to improve microvascular perfusion and left ventricular ejection fraction, but 
had no effect on infarct size (Basili et al., 2010; Ramos et al., 2017; Valls et al., 2016). Administration 
of radical scavenger Edavarone reduced infarct size and the incidence of arrhythmias in patients 
undergoing angioplasty (Tsujita et al., 2006). Despite these small scale studies reporting beneficial 
effects, large scale clinical trial data is missing.  
In light of the highly regulated nature of ROS signaling, recent studies have focused on the use of 
more targeted ROS modulation. For example, a preclinical guinea pig study found that the 
administration of mitoTEMPO, a mitochondria targeted ROS scavenger, can rescue heart failure 
induced by chronic catecholamine stimulation and pressure overload (Dey et al., 2018). It stands to 
reason that for these therapeutic approaches more knowledge about the spatial and temporal 
regulation of ROS signals is needed.  
2.2. Methods to detect and measure ROS 
One of the major challenges in redox research has been the detection of cellular ROS with high 
sensitivity and good spatial resolution. Traditional approaches have used dye based assays where 
reaction of ROS with a dye molecule leads to changes in its fluorescence, absorbance or light 
production. Widely used assays include dichlorodihydrofluorescein diacteate (H2DCF-DA), Amplex 
Red or dihydroethidium (DHE) probes.  
H2DCF-DA is a membrane permeable molecule, which is cleaved by cellular esterase upon entry and 
thus retained in cells. That way H2DCF can accumulate intracellularly with a tendency of enrichment 
in mitochondria (Rezende et al., 2018). Upon reaction with single electron oxidants such as O2
.- or 
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H2O2, fluorescent DCF is generated and can be detected by excitation at 495 nm and emission at 
529 nm. As the reaction of H2DCF to DCF is not specific to a single oxidant, the assay cannot give a 
clear answer as to the source of ROS observed. In addition, H2DCF is sensitive to oxidation by heme, 
NO2 and light (Marchesi et al., 1999).  
In contrast to H2DCF, horse raddish peroxidase (HRP) coupled assays such as Amplex Red provide 
specificity towards H2O2 mediated oxidation. In the presence of HRP and H2O2, Amplex Red is 
oxidized to resorufin, a molecule fluorescent at 590 nm emission upon excitation at 530 nm (Zhou et 
al., 1997). As Amplex Red does not enter cells, the assay is strictly extracellular, but can be used with 
isolated organelles, e.g. mitochondria. It is a highly sensitive assay but can react with light, 
peroxynitrite-derived radicals and mitochondrial carboxylesterase (Dębski et al., 2016; Miwa et al., 
2016; Zhao et al., 2012).  
DHE can be used to detect superoxide. It has been shown that DHE reacts via a radical intermediate 
to 2-Hydroxyethidium (2-OH-E+), a highly fluorescent substrate. However, analysis of 2-OH-E+ 
fluorescence can be confounded by other fluorescent side products such as ethidium that are 
generated by unspecific oxidations of DHE. Therefore, the most reliable detection of 2-OH-E+ is 
based on high performance liquid chromatography (Zielonka & Kalyanaraman, 2010). What makes 
DHE attractive for superoxide measurements is the possibility to target the probe to mitochondria. 
mitoSOX™ allows for the specific detection of mitochondrial O2
.- by generation of mito-2-OH-E+ 
(Robinson et al., 2006). As most dye based assays, also DHE is prone to oxidation by light, heme 
oxidases and auto-oxidation.  
A common feature of dye based assays is the accumulation of signal over time by irreversible 
oxidation of probe molecules. Although this mechanism leads to high sensitivity of ROS detection, it 
masks reversible ROS production and dynamic patterns of ROS bursts. Furthermore, phototoxicity 
and bleaching make long term measurements difficult.  
These issues can be overcome by recently developed fluorescent protein redox sensors. In general, 
these sensors are based on fluorescent proteins and will be produced by the cell of interest. They 
can easily be targeted to individual organelles by inclusion of signal peptides in the sensor coding 
sequence. They react with cellular ROS species in a reversible manner and can thus report dynamic 
changes in cellular ROS. In this study, we made use of two different fluorescent sensor systems, the 
GSH sensor Grx1-roGFP2 and the H2O2 sensor HyPer.  
Grx1-roGFP2 was developed based on enhanced green fluorescent protein (eGFP). Wild type GFP 
can exist at two different protonation states, the protonated A-band and the deprotonated B-band. 
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The A-band can be excited at 405 nm, while the B-band is excited at 488 nm. Excited state proton 
transfer leads to a deprotonation of the excited A-band by transfer of H+ to a neighboring amino acid 
outside of the fluorophore ring. This process leads to emission at the same wavelength of 510 nm for 
both protonation states (Figure 2 A) (Brejc et al., 1997; Chattoraj et al., 1996). In eGFP a S65T 
mutation leads to the stabilization of the protonated B-band and thus optimized fluorescence 
properties (Heim et al., 1995). When cysteines are introduced to the fluorescent barrel structure, 
disulfide bonds can form upon oxidation, leading to a conformational change that influences the 
protonation state and thus the fluorescent properties of the molecule. In case of roGFP2, S147C and 
Q204C mutations lead to a shift of excitation wavelength from 488 nm (protonated B-band) to 
405 nm (deprotonated A-band) upon oxidation (Figure 2 B) (Hanson et al., 2004). If expressed in the 
cell as roGFP2 alone, the equilibration to cellular oxidants is too slow and unspecific. By fusion of 
roGFP2 to redox relay proteins, specificity and fast equilibration can be achieved. Fusion to Grx1 for 
example gave rise to redox sensor Grx1-roGFP2, which is highly specific for cellular GSH (Gutscher et 
al., 2008). The reaction of Grx1-roGFP2 with cellular GSH/GSSG is fully reversible, which allows for 
the detection of dynamic changes of GSH/GSSG (Figure 2 C). Due to the ratiometric properties of the 
sensor, transgene expression level and photo bleaching do not compromise measurements. Other 
variants of roGFP2 based sensors include roGFP2-Orp1, which gains specificity to H2O2 induced 
oxidation from Orp1, a yeast peroxidase (Gutscher et al., 2009) and peroxiredoxin based probes 
roGFP2-Tsa2ΔCR and roGFP2-Tsa2ΔCPΔCR (Morgan et al., 2016).  
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Figure 2 Basic principle of fluorescent protein redox sensors. A) Fluorochrome protonation influences the excitation 
wavelength preference of fluorescent proteins, demonstrated here for GFP. The protonated A band is excited by 405 nm 
light, whereas the deprotonated B band is excited by 488 nm light. Both forms emit light at 509 nm, as excited state proton 
transfer to neighboring amino acids leads to the deprotonation of the excited A-band fluorophore. B) Redox sensitive 
mutations of fluorescent proteins change excitation wavelength upon oxidation or reduction. Fluorescence intensity over 
time after excitation with either 405 nm (blue) or 488 nm (green) light of roGFP2. Arrows indicate the point of addition of 
oxidative or reducing agents. C) Principle of Grx1-roGFP2 GSH dependent oxidation and reduction. Grx1-roGFP2 reacts with 
the cellular GSH/GSSG pool in a dynamic, reversible manner. Disulfide formation upon oxidation leads to a shift of 
excitation wavelength maxima. D) Principle of H2O2 sensor HyPer. cpYFP is integrated into bacterial H2O2 response element 
OxyR-RD. Upon reaction of OxyR-RD with H2O2, disulfide formation leads to major conformational changes resulting in an 
excitation wavelength shift of cpYFP.  
Another well studied H2O2 sensor is HyPer. HyPer was generated by insertion of a circularly 
permutated yellow fluorescent protein (YFP) between amino acids 205-206 of bacterial OxyR 
regulatory domain (OxyR-RD) (Belousov et al., 2006). OxyR is a bacterial transcription factor sensitive 
to H2O2 mediated oxidation. Upon reaction of the regulatory domain with an oxidant, major 
conformational changes lead to the initiation of redox defense gene transcription (Choi et al., 2001; 
Zheng et al., 1998). In case of Hyper, an oxidation of OxyR-RD leads to a shift in fluorescence 
properties of cpYFP (Figure 2 D). Similarly to GFP, YFP possesses two excitation maxima at 420 nm 
and 500 nm and one emission maximum at 516 nm. Oxidation of OxyR-RD leads to a decrease of 
fluorescence upon 420 nm excitation and a concomitant increase of fluorescence upon 500 nm 
excitation. The reduction of HyPer is most likely achieved via cellular GSH as demonstrated for wild 
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type OxyR in E.coli (Zheng et al., 1998). To ensure the specificity of the observed change in 
fluorescence, the redox active cysteines in OxyR-RD, Cys199 and Cys208 were mutated to serines. 
The resulting redox dead variants of HyPer do not react to H2O2, but can be influenced by changes in 
pH (Belousov et al., 2006). The C199S mutant is now known as cellular pH sensor SyPher and can be 
used as a suitable control in HyPer experiments (Matlashov et al., 2015). Newer versions of HyPer 
have been developed by further optimization of fluorescent properties. These variants termed 
HyPer2 and HyPer3 possess a larger dynamic range, stronger fluorescence and less pH sensitivity 
(Bilan et al., 2013; Markvicheva et al., 2011). In addition to the cpYFP based green sensors, a 
HyPerRed variant based on cpRed, a circularly permutated mApple, was developed. In contrast to 
the classical green HyPer probes, HyperRed is not ratiometric but rather intensiometric with an 
increase of fluorescence intensity upon oxidation by H2O2 (Ermakova et al., 2014). Another 
interesting application of HyPer has been the fusion to a D-amino acid oxidase. This HyPerDAO 
fusion protein can act as a sensor producer hybrid, with DAO producing H2O2 when supplied with D-
amino acids (Matlashov et al., 2014). Since intracellular production of H2O2 is very likely to have 
distinct effects from a general application of oxidants to the cell culture medium, this is an intriguing 
possibility to manipulate cellular redox homeostasis.  
Fluorescent protein based redox sensors offer many advantages over dye based systems, but they 
are inferior in the sensitivity towards oxidants. Most fluorescent protein based sensors can detect 
oxidants in the high nanomolar range. This includes physiological signals such as oxidative bursts but 
might not be sensitive enough for the detection of small scale ROS events such as very confined local 
ROS “sparks” in cellular microdomains, which might just be in the picomolar range.  
Examples of application of fluorescent protein based sensors have demonstrated that these sensors 
can indeed detect physiological ROS signals. Cell based assays have shown ROS involvement in 
apoptosis and growth factor signaling (Belousov et al., 2006). Recently, mice expressing Grx1-roGFP2 
or its mitochondria targeted version under the control of the cardiac α-myosin heavy chain (αMHC) 
promotor were used to investigate cellular redox potential in isolated adult myocytes (Swain et al., 
2016). Interestingly, in this study cardiac mitochondria possessed a more reduced GSH/GSSG pool 
compared to cytosol. Furthermore, cytoplasmic oxidation after stimulation with isoprenalin and 
Ang 2 could be visualized, as well as hypoxia-reoxygenation induced changes in cellular redox 
homeostasis. In a similar study, Orp1-roGFP2 and Grx1-roGFP2 were expressed in the developing 
zebrafish vasculature and heart. Live fluorescence imaging of transgenic fish embryos 48 hpf 
revealed differences in redox homeostasis between compartments, with mitochondria being more 
oxidized than cytosol or nucleus in all analyzed cell types. By inhibiting either pentose-phosphate-
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pathway or GSH synthesis, the involvement of metabolic pathways in cellular redox homeostasis was 
demonstrated (Panieri et al., 2017). While these two studies focused on the applicability of 
genetically encoded redox sensors in animal models, other studies have used redox sensors to 
complement their findings. In a guinea pig model of non-ischemic heart failure, adeno-associated 
virus serotype 9 (AAV9) mediated expression of Orp1-roGFP2 and mito-Orp1-roGFP2 was used to 
investigate changes in redox homeostasis in failing and non-failing hearts. Non-ischemic heart failure 
led to an increase in both cytosolic and mitochondrial ROS that could be rescued by application of 
the mitochondria targeted ROS scavenger mitoTEMPO (Dey et al., 2018). HyPer and two variants 
targeted to either caveolae or mitochondria were used in NOX4 and NOX2 knockout mice to 
investigate insulin induced ROS signals. H2O2 appeared to be produced in caveolae upon insulin 
stimulation in cardiomyocytes from wild type and NOX4 knockout mice, while wild type and NOX2 
knockouts demonstrated a cytosolic increase of H2O2 (Steinhorn et al., 2017). These results 
demonstrate how locally and temporally defined redox signals can be investigated using fluorescent 
protein redox sensors. However, they are restricted to animal models or stable human cell lines, 
which possess limitations in translation of findings to human pathology. Investigation of human 
cardiac redox biology needs suitable model systems that can also recapitulate complex cell-cell and 
cell-matrix interactions, which is not achieved in traditional cell culture assays. One such model 
system could be engineered heart muscles generated from stem cell derived cardiomyocytes and 
stromal cells. 
2.3. Stem cells and engineered tissues as model systems 
Pluripotent stem cells are cells that possess an unlimited self-renewal capacity and are able to 
differentiate into derivatives of all three germ layers. Embryonic stem cells as the classic pluripotent 
stem cell source are generated by isolation and expansion of inner cell mass of the preimplantation 
embryo under suitable growth conditions (Thomson et al., 1998). To avoid ethical concerns inherent 
to embryonic stem cells, protocols for the induction of pluripotency in adult differentiated cells were 
generated. Overexpression of four different transcription factors, Oct4, Klf2, Sox2, and c-myc is 
sufficient to reprogram cells back to a pluripotent fate (Takahashi et al., 2007; Takahashi & 
Yamanaka, 2006). Delivery of these four “Yamanaka factors” can be achieved for example by viral 
transduction, plasmid DNA transfection, protein electroporation or modified messenger RNA. As 
induced pluripotent stem cells (iPSCs) can be generated from apparently every individual, they are a 
very promising tool for the development of personalized therapies, screening platforms and 
regenerative medicine.  
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Furthermore, the rise of gene editing technologies like transcription activator-like effector nucleases 
(TALEN) or clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 has even added 
to the possibilities of stem cell use in model systems and therapies. Both technologies introduce 
mutations or target gene insertions by initially inducing a DNA double strand break at a defined 
location. If double strand breaks are repaired by non-homologous end joining, short insertions or 
deletions (so called indels) can lead to frameshifts and subsequent loss of protein function. When a 
donor fragment with homology sequences is supplied, homology directed repair will lead to the 
integration of donor sequences. Through this transgenes can be inserted or genomic sequences 
replaced. This allows also for the replacement of “defective” genes with corrected sequences, which 
can be used to verify disease causing mutations in patient derived iPSC of varying genetic 
background. Historically, the first technology developed for targeted double strand breaks were 
engineered zinc-finger nucleases. They consist of an array of six zinc-finger DNA binding domains, 
each recognizing a three basepair triplet fused to a FokI endonuclease. In order to cut DNA, FokI 
needs to dimerize. This requires the design of two Zinc-finger nucleases, binding the targeted DNA 
sequence in close proximity (Urnov et al., 2010). Similar to zinc-finger technology are TALENs. TALEs 
are proteins from the bacteria species Xhanthomonas with a DNA binding domain consisting of 
several 33-35 amino acid repeat domains. DNA binding is mediated via the repeat-variable di-residue 
(RVD) within this repeat domain. Each RVD binds a specific DNA base, thereby; TALEs can be 
engineered to recognize any basepair sequence on DNA (Boch et al., 2009).  Fusion of a FokI 
endonuclease domain then confers DNA cutting (Christian et al., 2010; Miller et al., 2011). Also 
TALENs need to dimerize on the target sequence to initiate DNA cleavage. Although TALENs work 
very similar to zinc finger nuclease, they were described to have less cytotoxic side effects when 
used for genome editing (Mussolino et al., 2011). 
In contrast to dimerizing nucleases, CRISPR/Cas9 protein can cut DNA directly when binding to the 
target sequence. CRISPRs are RNA-protein complexes of CRISPR protein, a tracrRNA, and a crRNA, 
the latter giving binding specificity (Cong et al., 2013; Jinek et al., 2012; Mali et al., 2013). As only a 
complementary RNA sequence is required for targeting of CRISPRs, the design is simplified in 
comparison to zinc-finger nucleases or TALENs. In addition, CRISPR/Cas9 is cutting DNA with a higher 
efficiency than TALENs, which can also be a downside with more unspecific sequences also targeted.  
Recent reports have highlighted the activation of p53 DNA damage response upon Cas9 induced 
DNA double strand breaks, a process that might increase CRISPR/Cas9 toxicity and inhibit efficient 
transgene integration (Haapaniemi et al., 2018; Ihry et al., 2018). Advances in the delivery of 
CRISPR/Cas9 as ready formed ribonucleoprotein complexes have reduced off-target effects and 
cytotoxicity (Farboud et al., 2018). Notably, the high efficiency of CRISPR DNA binding can also be 
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used for other applications. So-called nuclease-dead variants without DNA cutting properties have 
been fused to transcriptional activators or epigenetic modulators to manipulate and fine-tune gene 
expression patterns (La Russa & Qi, 2015; Xu & Qi, 2019). While these applications are still being 
developed and optimized, they offer exciting possibilities for future research and therapy.  
Soon after the establishment of stem cell culture, protocols for the differentiation into various cell 
types were developed. Early differentiation protocols assemble cells in hanging drops to form 3D 
embryoid bodies mimicking the physiological environment of these cells. In recent years, many of 
these protocols have been adapted to 2D culture conditions. By supplementation with different 
growth factors and small molecules, signaling pathways are fine-tuned to enrich cell types of 
interest. In cardiac differentiation it is known from embryology that cardiac mesoderm specification 
is driven by activation of wnt and bone morphogenetic protein (BMP) signaling, while subsequent 
cardiac specification relies on the inhibition of wnt signaling (Später et al., 2014). Typically, 
mesoderm specification is induced in culture by treatment with recombinant BMPs (Burridge et al., 
2011) and CHIR, a small molecule inhibitor of glycogen synthase kinase 3β, which, in turn, is a wnt 
inhibitor (Bennett et al., 2002). Subsequent wnt inhibition is achieved by supplementation with small 
molecules of the inhibitor of wnt production (IWP) family, typically IWP2 or IWP4. IWPs inhibit 
porcupine, an O-acyltransferase necessary for palmitoylation, and thus stability and secretion of wnt 
(Chen et al., 2009). Further enrichment of cardiomyocytes can then be achieved by metabolic 
selection with glucose free, lactate rich media, as lactate is preferably metabolized by 
cardiomyocytes. These classical differentiation protocols give rise to predominantly ventricular 
cardiomyocytes (Burridge et al., 2014; Lian et al., 2013; Weng et al., 2014). Adaptations have been 
developed to enrich other cardiomyocyte subtypes, such as atrial myocytes, which can be induced 
by additional treatment with retinoic acid (Cyganek et al., 2018; Devalla et al., 2015; Laksman et al., 
2017; Lee et al., 2017). 
One major issue pertaining to the differentiation of cardiomyocytes is the lack of full maturation of 
these cells. Stem cell derived cardiomyocytes usually attain a fetal phenotype. They express lower 
amounts of key Ca2+ handling proteins such as RyR2, SERCA, and calsequestrin 2 and show 
expression of fetal sarcomeric isoforms myosin heavy chain 6 (MYH6) and titin N2A (van den Berg et 
al., 2015). In contrast to isolated adult cardiomyocytes morphology is more rounded with shorter, 
less aligned sarcomeres and rarely t-tubules (Gherghiceanu et al., 2011; Lundy et al., 2013). In 
addition, metabolism and electrophysiological properties differ further from an adult phenotype. 
Different strategies have been developed to increase the maturation of stem cell derived 
cardiomyocytes. Supplementation of hormones like thyroid hormone triiodothyronine or 
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glucocorticoid analog dexamethasone to culture media has been tested in several studies (Parikh et 
al., 2017; Yang et al., 2014); however the physiological relevance of these signaling molecules in 
cardiac maturation is not clear. Considering metabolism, stem cells and stem cell derived 
cardiomyocytes rely on a mainly glycolysis driven ATP generation whereas adult cardiomyocytes are 
characterized by a preference for fatty acid oxidation and oxdidative phosphorylation (Lopaschuk & 
Jaswal, 2010; Makinde et al., 1998). Supplementation of culture media with fatty acids and 
stimulation of oxidative phosphorylation by small molecule inhibition of Hif1α or lactate 
dehydrogenase A has shown to improve stem cell derived cardiomyocyte metabolism (Correia et al., 
2017; Hu et al., 2018). Also electrical stimulation of monolayer cardiomyocytes can be used in order 
to improve cellular Ca2+ handling (Kroll et al., 2017).  
It has been suggested that cultivation in a 3D environment enhances cardiomyocyte maturation and 
function in-vitro (Tiburcy et al., 2011). Following this approach, cardiac tissue engineering focuses on 
the generation of multicellular cardiac organoids, by embedding cardiomyocytes in extracellular 
matrix substrates. One very commonly used matrix in this process is collagen type I (Soong et al., 
2012; Tiburcy et al., 2014). For the development of functional heart muscle, a stromal cell type is 
necessary (Naito et al., 2006). It has been postulated that stromal cells help supply a cardio-
instructive environment (Christalla et al., 2012) and it was demonstrated that matrix remodeling by 
stromal cells is an integral part of early tissue formation (Schlick et al., 2018). Others have also 
supplemented cardiac organoids with endothelial cells, in order to achive vascular network 
formation (Tulloch et al., 2011). Apart from the cellular composition, the biomechanical cues 
delivered to the tissue also seem to impact force development and cardiomyocyte maturation. Cyclic 
stretch as well as passive stretch induced by different casting geometries seem to improve force 
generation and cardiomyocyte maturation (Abilez et al., 2018; Tulloch et al., 2011; Zimmermann et 
al., 2002, 2006). Further improvement of culture conditions include application of electrical 
stimulation regimens (Godier-Furnémont et al., 2015; Radisic et al., 2004; Ronaldson-Bouchard et al., 
2018) or modulation of metabolic supply of glucose and palmitate (Mills et al., 2017). Engineered 
heart muscle allows for the direct determination of generated force and tissue stiffness, important 
characteristics of native myocardium. Applications also include disease modelling, drug screening 
and regeneration (Eder et al., 2014; Jacob et al., 2016; Meyer et al., 2019; Tiburcy et al., 2017; Voges 
et al., 2017). Disease modelling with patient derived iPSC has been demonstrated for a patient with 
dilative cardiomyopathy caused by mutations in RNA-binding motif protein20, where the patient 
engineered heart muscle (EHM) phenotype was characterized by less force of contraction and less 
passive stress (Streckfuss-Bömeke et al., 2017). In another study, a gene therapy approach for 
Duchenne’s muscular dystrophy (DMD) based on exon skipping has been shown to rescue the DMD 
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phenotype in EHM (Long et al., 2018). These studies and others demonstrate how engineered heart 
muscle models can be used as a versatile tool to investigate cardiac physiology and disease. This is 
even enhanced by the possibility to generate tissues in multi-well platforms with optical read-out of 
heart muscle function in order to streamline and enhance screening applications (Jacob et al., 2016; 
Mills et al., 2017; Nunes et al., 2013).  
Apart from screening and disease modeling applications, engineered tissues also hold promising 
perspectives for the therapy of heart disease. EHM have been shown to improve cardiac function 
after myocardial infarction in rat and guinea pig models (Riegler et al., 2015; Weinberger et al., 2016; 
Zimmermann et al., 2006). Since tissue constructs could be made in any desired geometry, also 
applications as biological ventricular assist devices of pouch shaped constructs are possible (Yildirim 
et al., 2007). Although technical hurdles to the clinical realization of these ideas still exist, they might 
provide a solution to the increasing demand for transplantable organs in the future.  
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 Aims of the thesis 3.
Redox signaling is an integral part of cardiac physiology. With stem cell derived cardiomyocytes and 
engineered tissues, we have very versatile tools to investigate redox signaling in single cells and cell-
cell interactions. Application of fluorescent redox sensors in human stem cell derived 
cardiomyocytes had previously been demonstrated in our lab (Heta, 2017). In order to fully take 
advantage of redox sensor technology on all levels of our EHM generation process from pluripotent 
stem cell to cardiomyocyte to EHM, we sought to: 
(1) Generate human pluripotent stem cell lines with stable expression of GSH and H2O2 sensors; 
(2) Compare redox homeostasis between stem cells and stem cell derived cardiomyocytes in 
respect to cytosolic and mitochondrial GSH/GSSG pools; 
(3) Establish models of H2O2 sensing and production in human pluripotent stem cells and stem 
cell derived cardiomyocytes. 
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 Material & Methods 4.
4.1. Cell culture 
4.1.1. TSA201 
TSA 201 cells (ECCAC) were grown in Dulbeccos modified Eagle’s medium high glucose (4.5 g/l, 
DMEM) supplemented with 5% fetal calf serum (FCS) on standard cell culture vessels. Splitting was 
performed with 0.05% Trypsin-EDTA when cells reached confluency. Coverslips and imaging plates 
were coated with 0.1% gelatin in sterile H2O for 20 min at room temperature prior to cell seeding. 
Cells were seeded at 0.05*106 cells / cm2.  
4.1.2. HFF 
Human foreskin fibroblasts (HFF) were grown in high glucose DMEM supplemented with 15% FCS 
and 100 U/mL penicillin, 100 μg/mL streptomycin. Cells were split using TrypLE digestion. In general, 
passages 20 to 30 were used for experiments. 
4.1.3. HES2 
Human embryonic stem cells (HES2, ESI Singapore) were grown on irradiated HFF as feeder layers in 
Knock-out DMEM supplemented with 20% Knock-out Serum Replacement, 2 mM glutamine, 1% 
non-essential amino acids (NEAA), 100 U/mL penicillin, 100 μg/mL streptomycin, and 10 ng/µl 
fibroblast growth factor 2 (FGF2). Cells were split using TrypLE, resuspendend in HES medium 
supplemented with 5 µM rho-associated kinase (ROCK) inhibitor Y27632 (Stemgent) and seeded at 
4*103 cells / cm2 for subculture. ROCK inhibitor was included until 24h after seeding. E8 medium 
(stem cell technologies) was used for feeder free cultures and differentiation on 1:120 Matrigel™ in 
sterile phosphate buffered saline (PBS) coated cell culture vessels.  
4.1.4. hCM 
Differentiation of pluripotent stem cells to human cardiomyocytes (hCM) was performed as 
previously described (Tiburcy et al., 2017). Briefly, stem cells where seeded under feeder free 
conditions at optimized densities on differentiation day -4 in E8. Mesoderm differentiation was 
induced at d0 by a combination of activin A, BMP4, CHIR and FGF2 in serum free Roswell Park 
Memorial Institute 1640 (RPMI 1640) medium (RPMI 1640 supplemented with 2% B27, 200 mM L-
ascorbic acid and 100 U/mL penicillin, 100 μg/mL streptomycin). From d4 to d13, serum free RPMI 
medium was supplemented with 5 µM IWP4. Cardiomyocytes were purified by metabolic selection 
in glucose free lactate containing medium. Differentiation ended at d21. For subsequent 
experiments, hCM were dissociated by incubation with Accutase, 0.025% trypsin, 20 µg/ml DNaseI 
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for 20 min at room temperature and reseeded onto 1:120 Matrigel™ in PBS coated cell culture 
vessels.  
4.1.5. EHM 
Engineered heart muscle was generated as previously described (Tiburcy et al., 2017). EHM used in 
this study were kindly generated by S. Schlick and S. Nagel, both Institute of Pharmacology and 
Toxicology.  
4.2. Cloning 
For all cloning approaches, insert coding sequences were amplified by polymerase chain reaction 
(PCR) using Primestar-HS (takara) or ExTaq (takara) DNA polymerase according to the 
manufacturer’s protocols. Through the use of carefully designed primers, restriction endonuclease 
recognition sites were integrated at the 5’ and 3’ end. For ExTaq PCR, up to 500 ng or template DNA 
were mixed with 5 µl 10x buffer, 1 µl of each forward and reverse primer (10 µM), 4 µl 2.5 mM 
dNTPs and 0.25 µl ExTaq (5 U/µl). Volume was adjusted to 50 µl using H2O. PCR was run in a 
standard table top thermocycler according to Table 1. Primestar-HS PCR was carried out using up to 
200 ng template DNA with 10 µl 5x PrimeStar buffer Mg2+, 4 µl 2.5 mM dNTPs, 1 µl of each forward 
and reverse primer (10 µM) and 0.5 µl PrimeStar Polymerase in a total volume of 50 µl. A three step 
cycling protocol as outlined in Table 2 was used. A comprehensive list of primers used can be found 
in the Appendix (Table 7).  
Table 1 Thermocycling protocol for ExTaq PCR 
  T (°C) t (mm:ss) 
initial denaturation 98 03:00 
30 cycles 
denature 98 00:10 
anneal  Tm 00:30 
extend 72 01:00 / kb 
final extension 72 10:00 
hold 4 ∞ 
 
Table 2 Thermocycling protocol for PrimeStar-HS PCR 
  T (°C) t (mm:ss) 
30 cycles 
denature 98 00:10 
anneal Tm 00:05 
extend 72 01:00 / kb 
final extension 72 05:00 
hold 4 ∞ 
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PCR products were run on 1 - 1.5% agarose gels containing 1:200 Midori Green DNA dye and 
analyzed using a GelDoc XR imager with UV illumination and ImageLab software. Fragments were cut 
from the gel and cleaned using NucleoSpin Gel and PCR clean up kit.  Restriction digest of up to 1 µg 
of insert and vector DNA was carried out overnight at the incubation temperature recommended by 
the manufacturer, usually 37°C (see Table 3 for a list of enzymes used). Restriction enzymes were 
heat inactivated and DNA fragments either run on agarose gel and cleaned from cut out bands 
(backbone vectors) or directly cleaned from the digestion reaction (insert fragments). Ligation was 
carried out at 16°C overnight with T4 ligase (NEB). Reactions were set up according to 
manufacturer’s instructions with molar ratios of backbone vector to insert of 1:3 up to 1:20. Ligation 
products were transformed into chemically competent bacteria (E. coli TOP10, prepared in-house) 
by heat shock. 50 µl of competent bacteria were mixed with 5 µl of ligation reaction and incubated 
for 30 min on ice. Heat shock was performed for 45 s at 42°C, followed by addition of 500 µl super 
optimal broth with catabolite suppression (SOC) medium and incubation at 37°C shaking at 300 rpm 
for one hour. Bacteria were plated on lysogeny broth (LB) agar plates containing selection antibiotic 
(100 µg/ml ampicillin) and incubated at 37°C overnight. Next day, colony PCR was carried out using 
FastGene Taq 2x Ready Mix. A PCR mastermix containing 5 µl FastGene 2x Ready Mix, 0.2 µl of each 
primer (10 µM) and 4.6 µl H2O per reaction was prepared and 10 µl added to each reaction tube. 
Colonies to screen were picked with a sterile pipette tip from which a copy plate was inoculated 
before the remaining bacteria were resuspended in PCR mastermix. Cycling was performed 
according to Table 4. PCR products were analyzed on a 1% agarose gel. When positive clones were 
detected, 5 ml liquid LB culture containing selection antibiotic were inoculated with bacteria from 
the copy plate and grown overnight at 37°C on a shaking platform. DNA was purified from 5 ml 
cultures with NuceloSpin mini Kit (macherey nagel) according to the manufacturer’s protocol. 
Plasmid DNA was subjected to test digestion and sequencing for confirmation of correct insert 
integration. Successfully cloned constructs were further amplified by inoculation of 200 ml liquid LB 
culture. After overnight incubation at 37°C on a shaking platform, DNA was purified with NucleoSpin 
midi kit and resuspended in up to 200 µl H2O. 





inactivation  manufacturer purpose 
AgeI ACCGGT 37 65 NEB cloning 
EcoRV-HF GATATC 37 65 NEB cloning 
KspAI-FD GTTAAC 37 65 thermo fisher cloning 
NotI-FD GCGGCCGC 37 80 thermo fisher cloning 
PacI TTAATTAA 37 65 NEB cloning 
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SalI-HF GTCGAC 37 65 NEB cloning 
SbfI CCTGCAGG 37 80 NEB test digest 
ScaI-FD AGTACT 37 65 thermo fisher linearization of donor vectors  
SpeI ACTAGT 37 80 NEB cloning 
XbaI-FD TCTAGA 37 65 thermo fisher cloning 
XhoI CTCGAG 37 65 NEB test digest 
 
4.2.1. pAAVS1 donor constructs 
A pAAVS1 homology site containing integration vector was obtained from system biosciences 
(cat# GE602A-1). Previous to this study, the original phosphorglycerate kinase (PGK) promotor had 
been replaced by a CMV early enhancer chicken beta actin rabbit beta globin (CAG) promotor 
(pAAVS1-CAG). Furthermore, the GFP coding sequence had been removed by restriction digest with 
FseI and BmgBI and subsequent vector relegation. The remaining base pairs caused a frameshift in 
the puromcyin open reading frame (ORF), leading to a non-functional selection cassette. A site 
directed mutagenesis approach for correction was carried out. In this, the elongation factor 1 (EF1) 
promotor and the pruomycin ORF were amplified separately using primers that generated an 
overlapping sequence at the 3’ end of the EF1-fragment and the 5’ end of the puromycin fragment 
(Figure 3 A). Additionally, restriction cut sites for KspAI and NotI were inserted. PCR products were 
cleaned from the reaction mix and joined by PCR using 3’ and 5’ flanking primers. The frameshift 
EF1-puromycin fragment was cut from pAAVS1-CAG by digestion with KspAI and NotI. The corrected 
EF1-puro fragment was also digested with KspAI and NotI. Subsequently, the corrected EF1-puro 
fragment was ligated to pAAVS1-CAG and correct insertion verified by colony PCR, restriction digest 
and sequencing. In order to facilitate cloning of redox sensor constructs into the pAAVS1-CAG-EF1-
puro, a custom multiple cloning site (MCS) was inserted downstream of the CAG promotor (Figure 3 
B). Oligonucleotides encoding the cutsite sequence for EcoRV-SbfI-AgeI-PacI-SalI were supended in 
10 mM TRIS pH 8, 50 mM NaCl, 1 mM EDTA at a final concentration of 40 nM of each oligonucleotide 
and annealed by incubation at 95°C for 10 min in a metal rack and subsequently left to cool to room 
temperature. pAAVS1-CAG-EF1-puro was digested with SalI and EcoRV and ligated with MCS 
duplexes. Correct integration was verified by colony PCR, restriction digest and sequencing (pAAVS1-
MCS-EF1-puro).   
Grx1-roGFP2 and mito-Grx1-roGFP2 coding sequences were amplified by PCR from pLPCX backbone 
vectors (a kind gift by Tobias Dick, Heidelberg) and restriction overhangs for SalI and PacI inserted. 
After digestion of pAAVS1-MCS-EF1-puro and sensor fragments with SalI and PacI, ligation was 
performed. Correct insert integration was verified by colony PCR, restriction digest and sequencing. 
Please refer to Appendix for detailed vector maps.  
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Figure 3 Schematic of cloning strategies. A) Correction of puromycin frameshift by mutagenesis PCR. B) Insertion of a 
custom MCS downstream of CAG promotor. 
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HyPer and HyPerDAO coding sequences were amplified by PCR from a pAAVHy2DAAO-NLS plasmid 
(a kind gift by Vsevolod Belousov, Moscow) and restriction sites for EcoRV and SalI inserted. pAAVS-
CAG-MCS-EF1-puro and the sensor fragments were digested with EcoRV and SalI and ligated. Please 
refer to Appendix for detailed vector maps. 
4.2.2. pGIPZ lenti constructs  
pGIPZ-Grx1-roGFP2 for the expression of Grx1-roGFP2 was generated previously in our lab (Heta, 
2017). A fragment encoding mito-Grx1-roGFP2 under the control of a cytomegalovirus (CMV) 
promotor was amplivied by PCR from pLPCX backbone vector (a kind gift by Tobias Dick, Heidelberg) 
and restriction overhangs for XbaI and NotI inserted. pGIPZ backbone vector and CMV-mito-Grx1-
roGFP2 were digested with XbaI and NotI, fragments run on a agarose gel, respective bands cut out 
and cleaned. Subsequent ligation resulted in pGIPZ-mito-Grx1-roGFP2. Correct insert integration was 
verified by colony PCR, restriction digest and sequencing. Please refer to Appendix for detailed 
vector maps. 
4.3. TALEN mediated integration 
4.3.1. Linearization of donor vectors 
pAAVS1 donor vectors for sensor integration were linearized prior to TALEN co-transfection in order 
to facilitate homology directed repair. 20 µg of plasmid DNA were digested with ScaI in a 20 µl 
reaction volume according to manufacturer’s instructions. Linearized plasmids were cleaned using 
NucleoSpin Gel and PCR clean-up kit and eluted in 50 µl H2O.  
4.3.2. Sensor integration in TSA cells 
TSA cells were grown on 6-well plates and transfected using PolyFect (Qiagen) according to 
manufacturer’s instructions. Briefly, 2 µg total DNA (1777 ng linearized donor plasmid, 111 ng of 
each TALEN encoding vector) in 100 µl supplement free medium were mixed with 20 µl PolyFect and 
incubated at room temperature for 10 min. 600 µl complete growth medium were added to 
PolyFect-DNA Mix and transferred dropwise to cells. After 24 h recovery, selection with 1 µg/ml 
puromycin was initiated and increased to 2 µg/ml subsequently. Cells were split when confluency 
was reached and re-selected when GFP+ content in live FC fell below 80%.  
4.3.3. Sensor integration in pluripotent stem cells 
HES2 wild type cells were resuspended as described above (see 4.1.3) and electroporation carried 
out with the neon electroporator according to the manufacturer’s instructions. Briefly, 1*106 cells 
were pelleted and resuspended in 100 µl electroporation buffer R. The cell suspension was mixed 
with 5 µg total plasmid DNA (4444 ng linearized donor plasmid, 270 ng of each TALEN encoding 
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vector) and electroporation was carried out using the 100 µl neon tip and a single pulse at 1,200 V 
for 40 ms. Cells were immediately transferred onto fresh feeder plates with HES medium containing 
5 µM ROCK inhibitor Y27632. When cells reached confluency they were split onto 1:120 Matrigel™ 
coated plates in E8 medium and puromycin selection was carried out with 0.2µg/ml for five days. 
Surviving cells were split onto 1:60 Matrigel™ coated plates to allow the formation of single colonies. 
Fluorescent clones were marked and manually transferred onto a 96-well format. When individual 
clones reached confluency, they were consecutively transferred onto 48-well, 24-well and T25 
culture formats. A sample for DNA isolation and genotyping was taken at the first splitting from the 
T25 culture format. At passage 7 after electroporation, cells were seeded onto irradiated feeder cells 
in HES medium.  
4.3.4. Genotyping 
Genomic integration of transgenes was analyzed by PCR based genotyping. Genomic DNA of TSA and 
HES2 cells was isolated with NucleoSpin Tissue Kit (macherey nagel) according to the manufacturer’s 
instructions. Per sample 5 µl 2x FastGene Polymerase mix, 0.2 µl of each 10 µM primer and up to 
250 ng template DNA were mixed and the volume adjusted to 10 µl using bidest H2O. Primers used 
are given in the Appendix (Table 7), the thermocycling protocol is given in Table 4. PCR products 
were analyzed on a 1% TAE-agarose gel containing 1:2000 midori green DNA stain at 90 V for 60 min.  
Table 4 Thermocycling protocol for genotyping and colony PCR with FastGene polymerase 
  T (°C) t (mm:ss) 
initial denaturation 95 03:00 
35 cycles  denature 95 00:30 
anneal  Tm 00:30 
extend 72 01:00 / kb 
final extension 72 01:00 / kb 
hold 4 ∞ 
 
4.3.5. Transgene localization 
Transgene localization in HES2 was analyzed using the Universal GenomeWalker 2.0 kit (takara bio) 
according to the manufacturer’s instructions. PCR products obtained from secondary PCR were 
analyzed by Sanger sequencing (seqlab) and sequences aligned to donor vectors sequences with 
SerialCloner 3.0 and human genome sequences using BLAST (NCBI). 
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4.4. Lentiviral sensor expression 
4.4.1. Production of lentivirus 
TSA cells were seeded on 10 cm culture dishes and transfected with 3 µg packaging plasmid pPAX, 
3 µg envelop plasmid pMD2 and 2 µg expression plasmid pGIPZ-Grx1-roGFP2 or pGIPZ-mito-Grx1-
roGFP2 using Polyfect (Qiagen) according to manufacturer’s instructions. Medium supernatant was 
harvested after 72 h and viral titer tested with Lenti-X GoStix (clontech). Viral particles were 
concentrated using vivapure lentiSELECT 40 Purification and Concentration kit (Sartorius) according 
to manufacturer’s instructions. Virus concentrate was either directly used to transduce cells or 
aliquoted and stored at -80°C. 
4.4.2. Transduction of hCM and HFF 
For transduction of hCM or HFF, normal culture medium was supplemented with 2.5 µl/ml viral 
concentrate and 8 µg/ml polybrene. Cells were incubated for 48 h before the first medium change. 
After several media changes, viral titer was tested using the Lenti-X p24 Rapid Titer Kit (clontech) 
according to manufacturer’s instructions. When viral titer was below 12.5 pg/µl cells were 
considered virus free and experiments performed.  
4.5. Flow cytometry 
For live cell flow cytometry, 1*106 cells were resuspended in PBS supplemented with 5% FCS 
containing 1:100 Sytox Red Dead cell stain and incubated for 15 min at room temperature. Cells 
were then spun down at 300xg at 4°C for 4 min and resuspended in 300 µl of PBS for analysis. Dead 
cells were excluded from analysis based on Sytox staining. Fluorescence gates were set according to 
non-fluorescent control cells.  
Cell fixation for flow cytometry was carried out by incubation of 0.5 – 1*106 cells in 
2% paraformaldehyde (PFA) for 15 min at room temperature. After washing with PBS cells were 
resuspended in PBS and stored at 4°C until analysis. After 5 min of blocking and permeabilization 
with blocking buffer (PBS, 10% bovine serum albumin (BSA), 5% FCS, 0.5% Triton X-100), primary 
antibody staining was performed in blocking buffer at 4°C for 60 min. After three washes with 
blocking buffer, secondary antibody staining was performed together with Hoechst DNA staining at 
4°C for 45 min. Samples were washed twice with blocking buffer, then once with PBS and 
resuspended in PBS for flow cytometry analysis. For each sample a negative control was incubated 
only with secondary antibody and Hoechst. If directly labelled antibodies were used, Hoechst 
staining was done in parallel with primary antibody incubation. Single, intact cells were gated based 
on forward scatter (FSC) vs sideward scatter (SSC) and doublets excluded based on Hoechst DNA 
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stain. Gating was performed according to negative control samples. Analysis was performed with BD 
FACS Diva and Flowing2 software. All antibodies and dilutions used can be found in the Appendix 
(Table 6). 
4.6. Immunofluorescence 
For immunofluorescence staining, cells were grown on glass coverslips under growth conditions 
stated above. Cells were fixed with 4% PFA for 15 min at room temperature and stored in PBS at 4°C 
until staining. After one hour blocking with blocking buffer at room temperature (PBS, 10% BSA, 
5% FCS, 0.5% Triton X-100), primary antibody incubation was carried out at 4°C overnight. Next day, 
cells were washed three times for 5 min with PBS and secondary antibody staining carried out for 
one hour at room temperature. Slides were washed three times with PBS for 5 min and embedded 
on glass slides using Mowiol or Fluoromount-G. For antibodies and dilutions used, see Appendix  
(Table 6). Images were acquired using a Zeiss LSM710 confocal microscope and Zen software. Images 
were analyzed using FIJI-ImageJ and adobe illustrator. 
4.7. Live imaging of mitochondria 
Live cells were stained for active mitochondria using tetramethylrhodamine methylester (TMRM) 
according to manufacturer’s instructions. TMRM was reconstituted at 10 mM in methanol and 
stored at -20°C until use. Before use, TMRM was diluted to as final concentration of 50 nM in cell 
culture medium. For nuclear co-staining, 1:1000 Hoechst was added to the staining medium. Cells 
seeded on coverslips were stained for 30 min at 37°C in a humidified incubator, washed twice and 
imaged in either medium or imaging buffer. Images were acquired on a Zeiss LSM710 confocal 
microscope using Zen software and analyzed with FIJI-ImageJ and adobe illustrator. 
4.8. Plate reader based redox assays 
TSA cells were seeded onto optical bottom 96-well plates (zellkontakt and Thermo Fischer) in growth 
conditions stated above at a density of 1*105/cm2 in order to achieve confluency on the day of 
measurement. Redox compounds such as H2O2, DTT and D-alanine were prepared as 10x stocks in 
imaging buffer (114 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2 [1 mM CaCl2 for hCM], 10 mM 
HEPES; pH 7.4) on a round bottom 96-well plate. Before measurement, cells were washed twice with 
PBS and incubated in imaging buffer at 37°C. Plates were transferred to the 37°C heated plate reader 
(flex station3, molecular devices) and measurements performed. Wells were excited sequentially at 
405 nm and 488 nm and emission detected at 520 nm using a 515 nm cutoff filter. Fluorescence 
intensities were recorded every five second for a total of five minutes. At 60 s, 20 µl compound 
solution were automatically added and mixed by trituration. Raw data were analyzed using 
Microsoft excel and graph pad prism. Background fluorescence values from empty wells were 
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subtracted and the 405 nm / 488 nm ratio calculated. All ratios were normalized to the average of 
the respective baseline trace. 
4.9. Redox imaging 
Transgenic cells were seeded on 25 mm diameter glass coverslips using growth conditions stated 
above. Redox imaging was performed in imaging buffer (114 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 
2 mM CaCl2 [1 mM CaCl2 for hCM], 10 mM HEPES; pH 7.4) in a 37°C climate chamber on a Zeiss D1 
Observer microscope using ZEN image processing software (Zeiss). Images were acquired 
sequentially at 400 nm and 505 nm excitation using a YFP filter at 40x magnification every 3 s. H2O2 
or DTT were added after a stable baseline was reached at 30 s. Image analysis was carried out using 
FIJI-ImageJ with the Biovoxxel Toolbox, Python3.6 and GraphPad prism 7. Regions of interest (ROIs) 
were drawn by hand based on bright field and GFP images to correspond to single cells, as well as a 
background ROI not containing any cell per slide. Fluorescence intensities for each ROI in each 
channel were extracted and corresponding background values subtracted. The ratio of the corrected 
intensity values was normalized to the average of the baseline. Calculation of GSH redox potential 
(EGSH) was performed as previously described (Meyer & Dick, 2010).  
4.10. Western Blot 
4.10.1. Whole cell protein isolation 
For the preparation of whole cell protein lysates, transgenic cells were seeded on 6-well plates. 
When cells reached confluency, lysis was carried out by incubation with 100 µl Bäuerle buffer 
(20 mM HEPES, 350 mM NaCl, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 1% NP40, 20% glycerol, 
pH 7.9) with Complete mini proteinase inhibitor and PhosphoStop phosphatase inhibitor (both 
Roche) on ice. After scraping culture surface with cell scraper, cell lysates were incubated for 20 min 
at 4°C while shaking. Further homogenization was achieved by 20G syringe. Lysates were centrifuged 
for 20 min at 10,000 xg at 4°C and supernatants collected. Protein concentration was determined by 
Bradford assay and samples stored at -20°C until use.  
4.10.2. Fractionation of mitochondria and cytosol 
Mitochondria isolation was carried out according to published protocol (Acín-Pérez et al., 2008), 
with modifications noted below. Cells were dissociated as described above, counted and 30 - 40*106 
cells pelleted and washed with PBS. Pellets were frozen at -80°C to weaken the cell membrane and 
resuspended in 2 ml 83 mM sucrose, 10 mM HEPES, pH 7.2. Cell suspension was transferred into a 
2 ml dounce homogenizer and homogenized using 30 strokes with a tight fitting pestle. An equal 
volume of 250 mM sucrose, 30 mM HEPES, pH 7.2 supplemented with 2x complete mini protease 
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inhibitor (Roche) were added and centrifuged at 1000 xg for 5 min at 4°C. Supernatants were 
transferred to clean microcentrifuge tubes and mitochondria pelleted at 12000 xg for 15 min at 4°C. 
Supernatants were retrieved as cytosolic fraction and mitochondria pellet resuspended in 200 µl 
320 mM sucrose, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4. Protein content was quantified by Bradford 
assay and samples stored at -80°C until use.  
4.10.3. Bradford assay 
Protein samples were diluted 1:25 in H2O and prepared in triplicates. A standard curve with 
concentrations ranging from 4 ng/ml to 64 ng/ml BSA in H2O was prepared in duplicate. To each 
50 µl of protein solution, 200 µl of 1x Rotiquant solution (Roth) in H2O were added. After 5 min 
incubation at room temperature, OD595 was measured with flexstation3 (molecular devices). Protein 
concentrations were extrapolated from standard curve after subtraction of background signal.  
4.10.4. SDS-polyacrylamid gel electrophoresis and western blot 
35 µg total protein per sample were prepared with 4x Laemmli buffer (0.12 M Tris-HCl, 
0.025% Bromophenol blue, 8% SDS, 33.3% glycerol, 10% β-mercaptoethanol, pH 6.8) and incubated 
at 95°C for 5 min. 12% SDS-polyacrylamide gels with 4% stacking gel were prepared according to 
Table 5. Samples were loaded onto 12% SDS-polyacrylamid gels in running buffer (25 mM Tris base, 
200 mM glycine, 3 mM SDS) and run at 70 V until samples reached separating gel. Voltage was then 
increased to 120 V and gel run for 1 – 1.5 h until loading dye was running out. Proteins were 
transferred by semidry blotting onto polyvinylidene difluoride (PVDF) membrane using transfer 
buffer (62.2 mM Tris base, 10 mM glycine, 5 mM SDS, 20% methanol) and blotting for 1 h at 140 mA. 
Successful transfer was confirmed by staining with 0.1% Ponceau in 0.5% acetic acid, and 
membranes subsequently blocked with 5% non-fat milk powder in Tris-buffered saline with Tween 
(TBS-T; 20 mM Tris-HCl, 165 mM NaCl, 0.1% Tween-20, pH 7.6). Primary antibody incubation in 
5% non-fat milk powder in TBS-T was carried out at 4°C over night. After 3 washes with TBS-T for 
10 min, secondary HRP labelled antibody was incubated for 1 h at room temperature in 5% non-fat 
milk powder in TBS-T. Membranes were washed 3 times for 10 min with TBS-T. Antibody signal was 
detected using FemtoLucent HRP (G biosciences) according to manufacturer’s instructions on a 
GelDoc XR imager (BioRad). If reprobing with another primary antibody was to be performed, 
membranes were stripped by two times 10 min incubation with stripping buffer (200 mM glycine, 
3.5 mM SDS, 1% Tween-20, pH 2.2), followed by three washes for 10 min with TBS-T. Afterwards, 
membranes were blocked and incubated as described above. For a list of antibodies and dilutions 
used, please refer to Appendix (Table 6).  
28  MATERIAL & METHODS 
 
Table 5 Preparation of SDS-polyacrylamid gels 
 4% stacking gel 12% separating gel 
 








40 % Acrylamide 0.5 4% 3 12% 
0.5 M Tris pH 6.8 1.25 125 mM     
1.5 M Tris pH 8.8     2,5 375 mM 
10% SDS 0,05 0.10% 0,1 0.10% 
10% APS 0,05 0.10% 0,1 0.10% 
TEMED 0,005 0.01% 0,004 0.004% 
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 Results 5.
5.1. The GSH/GSSG redox milieu in subcellular compartments 
The GSH/GSSG system is the main cellular buffer system for ROS. Disturbances in redox homeostasis 
are believed to play an important role in the initiation and progression of cardiac diseases. The aim 
of the thesis was to develop a transgenic reporter system to optically assess the GSH/GSSG balance 
in human heart muscle. We therefore tested the GSH sensor Grx1-roGFP2 and a mitochondria 
targeted variant in TSA cells before exploring their applicability in undifferentiated HES2 and HES2 
derived cardiomyocytes.  
5.1.1. Grx1-roGFP2 can be targeted to specific compartments in TSA cells 
We generated expression plasmids for the genetic integration of GSH sensor Grx1-roGFP2 and its 
mitochondria targeted variant, mito-Grx1-roGFP2. Mitochondrial targeting is achieved through a 
signal peptide sequence from bacterial Atp9, an ATP synthase. In order to test the correct expression 
and localization of the sensors, TSA cells were transfected with linearized donor vectors and TALEN 
expression plasmids, targeting the AAVS1 locus for integration. Subsequent puromycin selection 
ensured the enrichment of cells with successful genetic integration (Figure 4 A). Co-staining with 
mitochondria marker TMRM revealed a co-localization with the GFP signal in mito-Grx1-roGFP2 cells. 
GFP fluorescence from untargeted Grx1-roGFP2 was distributed across the whole cell, including 
cytoplasm and nucleus. The localization of sensor to the two compartments was further 
corroborated by Western blot anaylsis of cellular fractions. Cytosolic and mitochondria protein 
fractions were plotted and membranes stained for GFP, respiratory chain components and 
glycerolaldehydephosphatedehydrogenase (GAPDH). Respiratory chain proteins were only 
detectable in mitochondria fractions, whereas GAPDH was enriched in cytosolic fractions (Figure 4 
B). For Grx1-roGFP2 cells, GFP was enriched in the cytosolic fraction, whereas mito-Grx1-roGFP2 
showed a strongly enriched GFP signal in the mitochondrial fraction. In both cases, a small amount 
of GFP was also detected in the other fraction, possibly due to the crude preparation of 
mitochondria.  
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Figure 4 Grx1-roGFP2 is expressed in a compartment specific manner in TSA cells. TSA cells were transfecte with donor 
vectors for either untargeted (Grx1-roGFP2) or mitochondria trageted (mito-Grx1-roGFP2) redox sensors. A) Live 
fluorescence imaging of GFP, nuclei (Hoechst) and mitochondria (TMRM) demonstrates successful targeting of Grx1-
roGFP2 to cytosol and mitochondria. Scale bars: 50 µm. B) Western blot of cytosolic (c) and mitochondria (m) protein 
fractions confirms sensor enrichment in the targeted fraction. Purity of fractionation is demontrated by respiratory chain 
complexes I-IV in mitochondria fractions (SDHB: succinate dehydrogenase complex iron sulfur subunit B, MTCO1: 
Cytochrome c oxidase I, UQCRC2: ubiquinol-cytochrome c reductase core protein II, ATP5A: ATP synthase subunit alpha). 
Figure and legend as published in (Trautsch et al., 2019). 
5.1.2. Plate reader based redox assays confirm function of Grx1-roGFP2 in TSA cells 
Upon oxidation the maximum excitation wavelength of the fluorescent redox sensor Grx1-roGFP2 is 
shifted from 488 nm to 405 nm. To test the function of Grx1-roGFP2 in TSA cells, we performed plate 
reader based redox assays. To this end, TSA cells were seeded on optical bottom 96-well plates and 
fluorescence intensity was measured upon excitation with 405 nm and 488 nm. An automated liquid 
handling system integrated in the plate reader was used to deliver redox active compounds such as 
H2O2 or DTT after baseline recording. In this assay, we were able to detect a concentration 
dependent increase of fluorescence intensity ratio R(405/488) upon oxidation for both cytosolic and 
mitochondria targeted sensors. In both cases, a concentration of 1 µM H2O2 was not sufficient to 
induce detectable sensor oxidation. In the cytosol, a maximum oxidized ratio of 4.190 ± 0.336, 
n = 11, was reached upon application of 100 µM H2O2 (Figure 5 A), whereas mitochondria appeared 
to be already maximally oxidized at 10 µM H2O2, with a maximum oxidized ratio of 2.806 ± 0.291, 
n = 7, upon application of 100 µM H2O2 (Figure 5 B). DTT application of concentrations up to 1 mM 
did not lead to visible reduction of the cytosol (minimum reduced ratio 0.817 ± 0.047, n = 12; Figure 
5 C). Mitochondria, however, demonstrated a reduction down to 0.485 ± 0.106, n = 6, minimum 
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reduced ratio when treated with 1 mM DTT (Figure 5 D). Taken together, these results indicate a 
higher oxidation capacity in cytosol compared to mitochondria, i.e. a more oxidized GSH pool in 
mitochondria of TSA cells.  
 
Figure 5 Grx1-roGFP2 expressed in cytosol or mitochondria of TSA cells reacts to oxidation and reduction. Fluorescence 
intensity upon excitation with 405 nm and 488 nm was recorded every 5 s and is displayed as the change of fluorescence 
ratio (R) over baseline (R0) as a function of time. TSA cells treated with indicated concentrations of H2O2 and DTT at 60 s. 
A, C) cytosolic localized sensor GRX1-roGFP2, B, D) mitochondria targeted sensor mito-Grx1-roGFP2. Error bars: SEM, 
n = 4 - 12. 
5.1.3. Genomic integration leads to redox sensor expression in HES2 
We aimed to integrate fluorescent redox sensors Grx1-roGFP2 and mito-Grx1-roGFP2 into the safe 
harbor AAVS1 locus on chromosome 19 of human embryonic stem cells. HES2 were electroporated 
with linearized donor vectors encoding for a redox sensor and a puromycin selection marker. In 
addition two plasmids encoding a TALEN system targeting the AAVS1 locus were co-electroporated. 
GFP positive clones were selected and expanded. Two lines, HES2 cyto#3, expressing Grx1-roGFP2 
and HES2 mito2#34, expressing mito-Grx1-roGFP2 were selected for further analysis based on their 
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fluorescence properties. Analysis of pluripotency marker expression by flow cytometry for Oct4, 
Nanog and Tra1-60 revealed no differences between transgenic lines and non-transgenic controls 
(Figure 6 A). PCR of genomic DNA demonstrated integration of sensor coding sequences in both lines 
(Figure 6 B, C). In conclusion, the integration and expression of fluorescent redox sensor did not 
influence pluripotency of the analyzed HES2 lines. 
 
Figure 6 Transgene integration does not influence pluripotency. HES2cyto#3 (expressing Grx1-roGFP2) and HES2mito2#34 
(expressing mito-Grx1-roGFP2) lines were obtained from electroporation of wild type HES2. A) After transgene integration, 
HES2 lines retain expression of pluripotency markers Oct4, Nanog, and Tra1-60. Flow cytometry analysis, error bars: SEM, 
data from n = 3 passages. B) Schematic of duplex PCR for genotyping of transgenic lines. Two primer pairs were used in a 
single PCR reaction giving rise to one band for Grx1-roGFP2 (black arrows, 165 bp) and one band for mitochondrial 
targeting sequence (red arrows, 348 bp). C) Representative agarose gel electrophoresis for genotyping of HES2 lines. 
pAAVS1 donor vectors are used as positive control. Figure panel A adapted from (Trautsch et al., 2019). 
We used a TALEN system to target integration of redox sensors to the AAVS1 safe harbor locus. 
Contrary to our expectations, we were not able to detect locus integration by PCR using primers 
overlapping genomic and transgene sequences. In order to evaluate where the sensor DNA was 
integrated, we performed a genome walking analysis. Genomic DNA from HES2 lines was digested 
using 3 different restriction enzymes, ligated with specific adapters and a nested PCR was performed 
(Figure 7 A). Agarose gel electrophoresis showed several bands for both lines and all three libraries 
analyzed. Six bands were cut out from HES2 cyto#3 libraries and 5 bands from HES2 mito2#34 
libraries, DNA cleaned and sent for sequencing (Figure 7 B). DNA fragments from HES2 cyto#3 bands 
1 and 2 annealed to chromosome 16, syntaxin 1β intron 1 (nucleotides 31009712-31009446, 
genome assembly GRCh38.p12), whereas the sequence recovered from HES2 mito2#34 band 4 
annealed to a promotor flank region on band p21 on chromosome 1 (nucleotides 43084907-
43085978). For all other DNA fragments analyzed, no sequencing results could be obtained due to 
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low DNA amount and quality. These results confirmed a random integration of sensor transgenes in 
the analyzed HES2 lines. Integration into further loci cannot be excluded, as we did not obtain 
sequence information for all bands present.  
 
Figure 7 Redox sensor transgenes integrated at random sites in the HES2 genome. A) Principle of genome walker 
integration site analysis. B) Secondary (nested) PCR products separated on a 1% agarose gel. Bands that were isolated from 
the gel and sequenced are marked by red boxes and numbered. AP1/2: adapter primer 1/2, GSP1/2: gene specific primer 
1/2, DL: DNA library. 
We next analyzed the expression of the integrated transgenes. Live cell flow cytometry of HES2 
cyto#3 and HES2 mito2#34 confirmed a uniform expression of sensor in both lines compared to wild 
type HES2 (Figure 8 A). Western blot of mitochondria and cytosol fractions confirmed a 
compartment enriched expression. In Grx1-roGFP2 expressing HES2 cyto#3, GFP was enriched in the 
cytosolic fraction, whereas mito-Grx1-roGFP2 line HES2 mito2#34 showed a strong GFP signal in the 
mitochondria fraction (Figure 8 B). Since random integration did not seem to attenuate GFP 
expression in these cell lines and picked clones were uniformly positive for redox sensor expression, 
we continued to analyze the sensor function.  
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Figure 8 Grx1-roGFP is expressed in the targeted subcellular compartments in transgenic HES2. A) Live cell flow 
cytometry demonstrated uniform expression of fluorescent sensor in transgenic HES2. B) Western blot of cytosolic (c)  and 
mitochondria (m) fractions shows enrichment of GFP in either cytosol (HES2 cyto#3) or mitochondria (HES2 mito2#34). 
Purity of fractionation is demontrated by respiratory chain complexes I-IV in mitochondria fractions (NDUFB8: NADH 
ubiquinone oxidoreductase subunit B8, SDHB: succinate dehydrogenase complex iron sulfur subunit B, MTCO1: 
Cytochrome c oxidase I, UQCRC2: ubiquinol-cytochrome c reductase core protein II, ATP5A: ATP synthase subunit alpha). 
Figure and legend adapted from (Trautsch et al., 2019). 
5.1.4. Undifferentiated HES2 show a more reduced cytosol compared to mitochondria 
Undifferentiated HES2 cyto#3 and HES2 mito2#34 were subjected to redox imaging to test for the 
function of the integrated redox sensor transgenes. Cells were sequentially excited using 400 nm 
and 500 nm light and emission recorded with a YFP filter set. After baseline recording, oxidizing 
(H2O2) or reducing (DTT) compounds were applied. We detected a concentration dependent increase 
in fluorescence ratio R(405/488) upon oxidation with H2O2, while reduction with DTT led to a 
concentration dependent decrease in R(405/488). In HES2 cyto#3, oxidation with 300 µM H2O2 led to an 
increase of fluorescent ratio to 1.98 ± 0.02, n = 241 (Figure 9 A), whereas reduction induced a ratio 
decrease to 0.72 ± 0.01, n = 197, at 10 mM DTT (Figure 9 C). Likewise, HES2 mito2#34 reacted to 
300 µM H2O2 with a maximum ratio increase to 1.78 ± 0.01, n = 182 (Figure 9 B), and a minimum 
ratio decrease to 0.57 ± 0.003, n = 193, upon treatment with 10 mM DTT (Figure 9 D). In both 
cellular compartments, cytosol and mitochondria, 1 µM H2O2 did not elicit a sensor response, while 
10 µM led to a moderate ratio increase. In mitochondria, 100 µM H2O2 were already able to induce 
maximal oxidation, while in cytosol, maximum oxidation was observed with 300 µM H2O2 only. 
Similarly, 10 µM DTT did not lead to changes in R(405/488) in neither cytosol nor mitochondria, while 
RESULTS  35 
 
moderate reduction was observed after application of 100 µM DTT. Concentrations of 1 mM to 
10 mM DTT appeared to induce full reduction in both compartments. Treatment of HES2 mito2#34 
with 1 mM DTT appeared to induce a stronger reduction response than treatment with 3 mM DTT 
(Figure 9 D). This was not observed with HES2 cyto#3 where reduction with DTT was concentration 
dependent, with 3 mM DTT eliciting stronger response than 1 mM (Figure 9 C). Further studies are 
needed to elucidate whether this difference in sensor response to DTT stimulation represents a 
physiological difference between the analyzed compartments. 
 
Figure 9 HES Grx1-roGFP2 and mito-Grx1-roGFP2 react to oxidation and reduction in a concentration dependent manner. 
Undifferentiated HES2 were subjected to redox imaging and fluorescence intensity upon excitation with 405 nm and 
488 nm was recorded every 3 s and is displayed as the change of fluorescence ratio (R) over baseline (R0) as a function of 
time. H2O2 or DTT were added at 30 s at the indicated concentrations. Error bars: SEM, n = 52 - 274. Figure and legend 
adapted from (Trautsch et al., 2019). 
Based on maximal oxidation and reduction responses or Grx1-roGFP2, the redox potential for 
GSH/GSSG (EGSH) can be calculated using the Nernst equation (Meyer & Dick, 2010). Based on our 
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findings, cytosolic EGSH in undifferentiated stem cells was -288.5 mV ± 1.5 mV (n = 197). 
Mitochondrial EGSH was significantly more oxidized with -277.3 mV ± 4.6 mV (n = 182).  
5.1.5. HES2cyto#3 and HES2 mito2#34 derived cardiomyocytes are developmentally 
impaired 
Transgenic HES2 lines were differentiated to cardiomyocytes using a 21 day protocol. Differentiation 
efficiency was assessed by flow cytometry analysis of cardiac α-actinin expression and GFP 
fluorescence. In HES2 cyto#3 and HES2 mito2#34 cardiomyocytes, α-actinin positive cells were also 
GFP positive (92.6% ± 1.9% and 85.1% ± 6.1% vs 0.1% ± 0.02% and 0.2% ± 0.1%, respectively, n = 3; 
Figure 10 A). In non-transgenic control cardiomyocytes, no GFP positive cells were detected. 
Interestingly, differentiation efficiency was similar to transgenic sensor lines with 81.8% ± 5.4 %, 
n = 3, α-actinin positive cells (Figure 10 A). Despite clear α-actinin expression, we did not observe 
spontaneous beating activity in sensor line derived cardiomyocytes in 10 out of 12 differentiations. 
Immunofluorescence analysis of α-actinin revealed a sarcomeric phenotype with less ordered 
sarcomeres and less strong striations in HES2 cyto#3 and HES2 mito2#34 compared to non-
transgenic controls (Figure 10 B). This functional phenotype was unexpected, as undifferentiated 
HES2 did not show any impairment of pluripotency. Furthermore, the identified integration sites 
where not associated with known cardiac genes (see also 5.1.3). Thus the data suggest a role for ROS 
in cardiomyocyte maturation and sarcomere assembly and a deleterious ROS buffering effect by 
constitutive Grx1-roGFP2 sensor expression. 
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Figure 10 Transgenic HES2 derived hCM show a sarcomeric phenotype. HES2 cyto#3 and HES2 mito2#34 were 
differentiated into cardiomyocytes. A) Flow cytometry analysis of α-actinin expression showed high differentiation 
efficiency and purity of cardiomyocytes. Error bars: SEM, n = 3. B) Immunofluorescence staining of α-actinin unmasks a 
disturbed sarcomere assembly in sensor line derived cardiomyocytes,   Insets show magnified view of sarcomeric striations, 
scale bars: 20 µm. Figure and legend adapted from (Trautsch et al., 2019). 
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5.1.6. Stem cell derived cardiomyocytes have more oxidized mitochondria  
Despite the observed phenotype, we checked the function of expressed redox sensors. Redox 
imaging of cardiomyocytes derived from HES2 cyto#3 and HES2 mito2#34 was performed, using 
100 µM H2O2 for oxidation and 1 mM DTT for reduction. Cytosolic sensor Grx1-roGFP2 reacted to 
100 µM H2O2 with an increase of fluorescence ration R(405/488) to 3.3 ± 0.01, n = 176 (Figure 11 A). 
Fluorescent ratio decreased to 0.9 ± 0.002 (n = 170), when 1 mM DTT was applied. Mitochondria 
displayed a smaller oxidation response of 2.0 ± 0.1 (n = 325), upon treatment with 100 µM H2O2, 
while minimum ratio after reduction with 1 mM DTT was 0.6 ± 0.005 (n = 325) (Figure 11 B). These 
findings indicate a more oxidized mitochondrial milieu in comparison to cytosol, which appears to be 
almost fully reduced at baseline. For further confirmation of these findings, a broader range of 
concentrations of H2O2 and DTT would need to be tested, in order to ensure maximum oxidation and 
reduction of the probe. As HES2 cyto#3 and HES2 mito2#34 derived cardiomyocytes displayed 
functional deficits, we decided to not investigate their redox milieu further.  
 
Figure 11 Redox sensors are functional in stem cell derived cardiomyocytes. Fluorescence intensity upon excitation with 
405 nm and 488 nm in redox sensor HES2 line derived cardiomyocytes was recorded every 3 s and is displayed as the 
change of fluorescence ratio (R) over baseline (R0) as a function of time. H2O2 and DTT were added after 30s baseline 
recording in the indicated concentrations. Error bars: SEM, n = 170 - 325. Figure and legend adapted from (Trautsch et al., 
2019).  
5.1.7. Redox imaging of engineered heart muscle 
It has previously been shown that 3D culture can mature cardiomyocytes and improve their function 
(Tiburcy et al., 2017). In an attempt to restore function of HES2 cyto#3 and HES2 mito2#34 derived 
cardiomyocytes, we generated engineered heart muscle from these cells together with primary 
human foreskin fibroblasts (HFF). To this end, cardiomyocytes and HFF were embedded in a collagen 
hydrogel and cast in ring shaped molds to allow tissue formation. EHM were then transferred to 
flexible stretchers, allowing further maturation by auxotonic force generation during the 28 day 
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culture period (Figure 12 A). In line with the observed disturbed sarcomere phenotype and the lack 
of contractility in monolayer culture, no contractile force was generated by redox sensor EHM during 
and after 28 days of maturation. However, sensor expression was retained during culture both in 
HES2 cyto#3 EHM as well as in HES2 mito2#34 EHM (Figure 12 B). In a proof-of-principle experiment, 
HES2mito2#34 EHM were subjected to redox imaging. Treatment with 100 µM H2O2 led to a 
detectable increase in fluorescence intensity in 405 nm excitation and a concomitant reduction of 
fluorescent intensity in 488 nm excitation. Conversely, reduction with 1 mM DTT had the opposite 
effect, leading to increased fluorescence intensity upon 488 nm excitation and reduced fluorescence 
intensity upon 405 nm excitation (Figure 12 C, D).  
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Figure 12 Redox signals are detectable in EHM. EHM were constructed from HES2 cyto#3 and HES2 mito2#34 derived 
cardiomyocytes. A) Schematic of EHM generation. Cardiomoyocytes (hCM) and fibroblasts (HFF) are embedded in a 
collagen (ColI) matrix. Ring shaped tissues are allowed to mature for 28 days on flexible stretchers. B) Brightfield and GFP 
images of 28 days old transgenic EHM shows retention of GFP expression during EHM maturation. Scale bars: 1 mm. C) 
False colored images of EHM redox imaging of HES2 mito2#34 EHM. Blue color represents 405 nm excitation, green color 
488 nm excitation. The shift in excitation maximum upon oxidation (100 µM H2O2) and reduction (1 mM DTT) can be 
appreciated. Scale bars: 500 µm. D) Quantification of fluorescence intensities upon oxidation (100 µM H2O2) and reduction 
(1 mM DTT) in HES2 mito2#34 EHM. H2O2 and DTT were added at 50 s. Solid lines: mean, dotted lines: SEM, n = 3 ROIs on 
one EHM.  
Although we were not able to induce spontaneous beating by generation of EHM, we were able to 
demonstrate the applicability of fluorescent redox sensors in EHM. We were able to attain sensor 
readouts in oxidation and reduction scenarios, highlighting how redox sensors can be used to 
investigate redox homeostasis from undifferentiated cells to differentiated derivates and 3D 
engineered tissues. Further studies are required to decipher the mechanism underlying the 
disturbance in cardiomyocytes function.  
5.1.8. Lentivirus mediated expression of mito-Grx1-roGFP2 
As we had previously established lentivirus mediated expression of Grx1-roGFP2 in differentiated, 
functional cardiomyocytes (Heta, 2017), we decided to further investigate mitochondria redox 
potential using mito-Grx1-roGFP2 lentivirus. Lentiviral particles for the expression of Grx1-roGFP2 
and mito-Grx1-roGFP2 were produced in TSA cells. Concentrated viral particles were used for the 
transduction of HFF and hCM. Correct localization of expressed sensors was confirmed by TMRM 
staining of mitochondria in live cells. In HFF, mitochondria appeared to form filamentous networks 
spread throughout the cells. The same pattern was detectable for mito-Grx1-roGFP2, while Grx1-
roGFP2 filled the cytoplasm and nucleus (Figure 13 A). A high background fluorescence signal in the 
405 nm channel was detected when analyzing nuclear staining using Hoechst, which did not co-
localize with either GFP or TMRM staining. The same was later apparent in redox imaging 
experiments, but did not impact evaluation. As lentiviral transduction did not occur in all cells, only a 
subset of the imaged HFF was GFP positive.  
Redox imaging of both sensors was performed in HFF. Upon treatment with 1 mM H2O2, maximum 
oxidized fluorescence ratio in the cytosol was 2.5 ± 0.1, n = 17, whereas mitochondria maximum 
oxidized ratio was 2.3 ± 0.1, n = 28 (Figure 13 C, D). In the cytosol, treatment with 100 µM H2O2 and 
10 µM H2O2 led to ratio increases up to 2.2 ± 0.1, n = 17, and 1.8 ± 0.1, n = 21, respectively. In 
contrast, mitochondria reacted to 100 µM H2O2 with a ratio increase close to maximal oxidation of 
2.6 ± 0.1, n = 29, while 10 µM H2O2 only induced a slight increase of up to 1.2 ± 0.1, n = 25, indicating 
a threshold for full oxidation between 10 µM and 100 µM H2O2. Conversely, application of DTT led to 
a decrease in fluorescence ratio (Figure 13 E, F). Minimum reduced ratio as achieved by application 
of 10 mM DTT was 0.7 ± 0.02, n = 18, in cytosol and 0.6 ± 0.02, n = 18, in mitochondria. Interestingly, 
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application of 100 µM DTT led to an initial ratio increase of Grx1-roGFP2 signal (1.1 ± 0.04, n = 12), 
while mito-Grx1-roGFP2 ratio decreased constantly over imaging time down to 0.9 ± 0.01, n = 27. 
1 mM DTT led to an intermediate ratio decrease to 0.7 ± 0.03, n = 20, in cytosol and 0.7 ± 0.01, 
n = 27, in mitochondria. In summary, these observations demonstrate a similar redox milieu in 
fibroblast mitochondria and cytosol with distinct kinetics when exposed to sub-maximal 
concentrations of reducing and oxidizing agents.  
RESULTS  43 
 
 
Figure 13 Transduced HFF report oxidation and reduction in cytosol and mitochondria A) Live fluorescence images of 
roGFP2 expression, nuclei (Hoechst) and mitochondria (TMRM) in HFF transduced with lentivirus for Grx1-roGFP2 or mito-
Grx1-roGFP2 showed localized expression of redox sensors. Note the high fluorescent background in the Hoechst channel 
(405 nm). Scale bar = 50 µm. B– E) Transduced HFF were subjected to redox imaging. Fluorescence intensity after 
excitation with 405 nm and 488 nm was recorded every 3 s and is displayed as the change of fluorescence ratio (R) over 
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baseline (R0) as a function of time. H2O2 or DTT were added at 30 s at the indicated concentrations. Error bars: SEM, 
n = 16 – 27. 
Based on our experience with Grx1-roFP2 lentiviral expression in cardiomyocytes and results 
obtained from mito-Grx1-roGFP2 expression in HFF, differentiated, functional cardiomyocytes were 
transduced with concentrated lentiviral particles for cytosolic and mitochondrial Grx1-roGFP2. Co-
staining of live cells with TMRM and Hoechst demonstrated mitochondria localization of mito-Grx1-
roGFP2 (Figure 14 A). Cardiomyocytes in both conditions were however small and rounded and 
mitochondria looked clustered and swollen. Despite the immature morphology, beating was 
observed in Grx1-roGFP2 and mito-Grx1-roGFP2 transduced cells, which indicated correct cellular 
function. In mito-Grx1-roGFP2 expressing cardiomyocytes, fluorescence signal was also detected in 
the mitochondria under 405 nm excitation.  
Subsequently, redox imaging was performed to investigate cardiomyocyte redox milieu in cytosol 
and mitochondria. Upon treatment with 1 mM H2O2, fluorescent ratio increased up to 3.7 ± 0.1, 
n = 47, in cytosol, while mitochondria showed less capacity for oxidation with a maximum oxidized 
ratio of 2.0 ± 0.1, n = 81 (Figure 14 A, B). This observation was confirmed when 10 mM DTT was 
applied to induce maximal reduction. Mito-Grx1-roGFP2 fluorescent ratio decreased to 0.5 ± 0.01 
(n = 97), while cytosolic fluorescent ratio was 0.8 ± 0.03, (n = 28, Figure 14 C, D). While application of 
an intermediate concentration of 1 mM DTT led to a ratio decrease in both compartments 
(0.9 ± 0.01, n = 50, for cytosol, 0.5 ± 0.02, n = 60, for mitochondria), 100 µM DTT led to a ratio 
increase of Grx1-roGFP2 up to 1.5 ± 0.04 (n = 42). This is in contrast to previously reported results by 
our group which did not report an oxidative response upon treatment with low concentrations of 
DTT in stem cell derived cardiomyocytes. As expected, mito-Grx1-roGFP2 fluorescence ratio 
decreased by treatment with 100 µM DTT to 0.7 ± 0.01, n = 44. Taken together, we observed a very 
distinct redox milieu in cytosol and mitochondria of stem cell derived cardiomyocytes. This indicates 
a very tight control of cellular redox milieu that might be directly linked to cellular function.  
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Figure 14 Transduced hCM mitochondria are oxidized compared to cytosol.  A) Live fluorescence imaging of GFP, nuclei 
(Hoechst) and mitochondria (TMRM) confirmed the compartment specific sensor expression after lentiviral transduction. 
roGFP2 fluorescence in mitochondria is also detected in the 405 nm channel (Hoechst). Scale bar: 50 µm. B-E) 
Cardiomyocytes transduced with lentivirus encoding Grx1-roGFP2 or mito-Grx1-roGFP2 were subjected to redox imaging. 
Fluorescence intensity after excitation with 405 nm and 488 nm was recorded every 3 s and is displayed as the change of 
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fluorescence ratio (R) over baseline (R0) as a function of time. H2O2 or DTT were added at 30 s at the indicated 
concentrations. Error bars: SEM, n = 20 – 97. 
5.2. Sensing and producing H2O2 in cell-cell interaction models 
While GSH sensors allow for monitoring of GSH/GSSG redox homeostasis in cells and tissues, they 
are limited as they only report changes in a cellular buffer system. Minor, more dynamic changes are 
likely happening at the level of individual ROS, such as H2O2. One genetically encoded sensor to 
monitor H2O2 in cells is HyPer. Apart from monitoring changes in cellular H2O2 levels, a novel fusion 
protein of HyPer and a D-amino acid oxidase, HyPerDAO offers the intriguing possibility to also 
manipulate intracellular ROS levels. It stands to reason that production of H2O2 inside the cell will 
follow different kinetics and exert different ROS stress on the cell than an application of H2O2 to the 
culture medium. In the second part of this thesis, we established expression of HyPer and HyPerDAO 
in TSA and HES cells and demonstrated function of sensor-producer complexes. 
5.2.1. HyPerDAO produces H2O2 in TSA cells 
We generated donor vectors for the genetic integration of HyPer and HyPerDAO. TSA cells were 
transfected with linearized donor plasmid and plasmids encoding components of a TALEN system 
targeting the AAVS1 safe harbor locus. Successful transfection gave rise to TSA HyPer and TSA 
HyperDAO cells with uniform expression of fluorescent redox sensors as detectable by GFP flow 
cytometry (Figure 15).  
TSA HyPer and TSA HyPerDAO were seeded on optical bottom 96-well plates and plate reader based 
redox assays performed. In both lines, HyPer reacted to oxidation by increasing concentrations of 
H2O2 with an increase in fluorescence ratio R(405/488). Maximum oxidation was achieved by 100 µM 
H2O2 and led to a ratio increase to 3.3 ± 0.2, n = 12, in HyPer (Figure 16 A) and 3.4 ± 0.2, n = 12, in 
HyPerDAO cells (Figure 16 B). 1 µM H2O2 did not induce oxidation of the sensor, while 10 µM H2O2 
led to a moderate increase of fluorescence ratio. Upon treatment with DTT, no change in fluorescent 
ratio was observed (0.94 ± 0.02, n = 12 for HyPer and 0.93 ± 0.02, n = 12 for HyPerDAO; Figure 16 C, 
D). It has been postulated that intracellular HyPer is reduced by components of the GSH system. As 
previously observed with cytosolic Grx1-roGFP2 expression in TSA cells, the cytosolic GSH/GSSG pool 
is already highly reduced at baseline. The same might be true for HyPer in this case.  
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Figure 15 TSA cells express HyPer and HyPerDAO. A) Example dot plots of live cell flow cytometry shows uniform 
transgene expression. B) Transgene expression is stable over passages and uniform in HyPer and HyPerDAO TSA cells. Live 
flow cytometry analysis, error bars: SEM, n = 3. 
When D-amino acids such as D-alanine are present, DAO will oxidize these amino acids to their 
corresponding pyruvic acid. In this reaction, H2O2 is generated as a byproduct (Figure 16 E). When 
adding 8 mM D-alanine to HyPerDAO TSA cells, the produced H2O2 leads to an increase in 
fluorescent ratio R(405/488) to 2.3 ± 0.2, n = 12 (Figure 16 F). This increase is not visible in cells 
expressing only HyPer (R(405/488) = 1.0 ± 0.02, n = 12). HyPerDAO thus allows for the targeted 
production of H2O2 restricted to cells harboring this specific transgene.   
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Figure 16 HyPer and HyPerDAO is functional in TSA cells. TSA cells expressing either HyPer (A, C) or HyPerDAO (B, D) were 
treated with indicated concentrations of H2O2 and DTT. Fluorescence intensity upon excitation with 405 nm and 488 nm 
was recorded every 5 s and is displayed as the change of fluorescence ratio (R) over baseline (R0) as a function of time. 
H2O2 and DTT were added after 60 s. Error bars: SEM, n = 11 - 12. E) HyPerDAO acts as a sensor-producer hybrid for H2O2. 
The oxidation of D-alanine by DAO gives rise to H2O2 which is in turn detected by HyPer. F) Cells expressing HyPer or 
HyperDAO were treated with 8 mM D-alanine at 60 s and fluorescence intensitiy recorded for excitation wavelenghts 
405 nm and 488 nm. Only when DAO is present, an increase in cellular H2O2 concentration is detected. Error bars: SEM, 
n = 12. 
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5.2.2. HES2 integrate and express HyPer expression sequences  
As HyPer and HyPerDAO offered intriguing possibilities to analyze and manipulate the redox 
homeostasis in stem cell derived cardiomoycytes, we set out to generate stem cell lines expressing 
HyPer or HyPerDAO.  
HES2 were electroporated with linearized donors vectors for HyPer and HyperDAO as well as two 
plasmids encoding a TALEN system targeting the AAVS1 locus. Single cells clones were selected 
based on fluorescence and genotyping for genomic integration performed (Figure 17 C, D). Based on 
the results, one HES2 line expressing HyPer (HES2 HyPer#5) and one line expressing HyperDAO 
(HES2 HyPerDAO#5) were chosen for further investigation. Pluripotency was confirmed by flow 
cytometry analysis of Oct4, Nanog and Tra1-60 expression. Both transgenic lines showed similarly 
high expression of pluripotency markers as non-transgenic control cells (Figure 17 A). The correct 
expression of sensor protein was further confirmed by Western blot analysis using a GFP antibody. 
The larger HyPerDAO fusion protein (estimated molecular weight 93 kDa) was clearly separated from 
HyPer, which is around 53 kDa in size (Figure 17 B).  
 
Figure 17 HyPer expression in HES2 does not influence pluripotency. A) Pluripotency analysis of HES lines expressing 
HyPer (HES2 HyPer#5) or HyPerDAO (HES2 HyPerDAO#5) shows expression of pluripotency markers Oct4, Nanog and Tra 1-
60 after transgene integration. B) Western blot demonstrates expression of HyPer and HyPerDAO transgenes in analyzed 
lines. Due to the fusion with DAO, HyPerDAO is approximately 93 kDa, whereas HyPer is 53 kDa in size. C) Schematic of 
duplex PCR for genotyping of transgenic lines. Two primer pairs were used in a single PCR reaction giving rise to one band 
for HyPer (black arrows, 171 bp) and one band for DAO (red arrows, 296 bp). D) Representative agarose gel electrophoresis 
for genotyping of HES2 lines. pAAVS1 donor vectors are used as positive control. 
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Similarly to the Grx1-roGFP2 transgenic lines, we were not able to verify integration in the AAVS1 
locus for HES2 HyPer#5 and HES2 HyPerDAO#5. This led us to assume that also in this case, 
transgenes most likely integrated randomly. We performed test differentiations of HyPer and 
HyPerDAO lines towards cardiomyocytes, but in line with roGFP2 lines, no spontaneous beating was 
observed. We therefore decided to discontinue experiments with these lines and focus on a more 
efficient CRISPR/Cas9 approach for genomic integration.   
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 Discussion 6.
Redox signaling plays a major role in cardiac homeostasis and disease. The coordinated production 
of ROS in a defined spatial and temporal manner by NOXs can exert manifold effects on 
cardiomyocyte function. Contractility, metabolism and even gene transcription are regulated by 
redox modifications of key signaling proteins. ROS production by mitochondria can also influence 
these pathways and is an integral part of metabolic regulatory networks. Measurements of cellular 
ROS are however limited by the use of traditional dye based detection systems, which do not allow 
for repeated and long term studies. With the development of fluorescent redox sensors, tools for 
the dynamic, in-situ analysis of ROS and the cellular ROS scavenging systems are available.  
In the present study, we investigated the use of genetically encoded redox sensors in human 
pluripotent stem cells, human dermal fibroblasts, differentiated cardiomyocytes and engineered 
heart muscle. HES2 lines with genetic integration of GSH redox sensors Grx1-roGFP2 and mito-Grx1-
roGFP2 as well as H2O2 sensor HyPer and sensor-producer hybrid HyPerDAO were generated. As 
cardiomyocytes differentiated from these lines displayed deficits in sarcomere assembly, in addition 
lentiviral transduction of stem cell derived cardiomyocytes and dermal fibroblasts for compartment 
specific expression of Grx1-roGFP2 was performed. Redox imaging revealed differences in GSH/GSSG 
balance between stem cells, cardiomyocytes and fibroblasts, highlighting the importance of cell type 
specific redox imaging.  
The main findings of this study are: 
- Genetic integration of redox sensors does not impair pluripotent stem cell marker 
expression, but impairs sarcomere assembly of differentiated cardiomyocytes. 
- Analysis of Grx1-roGFP2 and mito-Grx1-roGFP2 by redox imaging allows for the 
determination of compartment specific GSH/GSSG redox balance in human embryonic stem 
cells, human dermal fibroblasts, stem cell derived cardiomyocytes and engineered heart 
muscle. 
- In undifferentiated human embryonic stem cells as well as human stem cell derived 
cardiomyocytes, the mitochondria GSH/GSSG pool is more oxidized than the cytosol.  
- In contrast to cardiomyocytes, fibroblast GSH/GSSG balance appears similar between cytosol 
and mitochondria.  
- H2O2 sensor-producer construct HyPerDAO allows for targeted manipulation of cellular 
redox balance. 
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6.1. Genomic integration in embryonic stem cells 
In order to establish a pipeline for the investigation of cellular redox milieus in human stem cell 
derived cardiomyocytes and EHMs, genetic integration of redox sensors in human embryonic stem 
cells was performed. Although a TALEN system targeting the AAVS1 locus on human chromosome 19 
was used for the integration of redox sensors, transgenes integrated randomly. In principle it is not 
expected that this leads to an impact on cardiomyogenesis, however, we observed an impaired 
beating function upon differentiation of transgenic HES lines. This phenotype cannot be explained 
completely by random transgene integration, as we analyzed integration sites and found no cardiac 
association of the genes or regions disrupted. Furthermore, traditional transgene models such as the 
Grx1-roGFP2 mouse model (Swain et al., 2016) often rely on random integration of target genes. 
Usually, tissue specific promotors are chosen for the expression of the integrated transgenes. 
However, in our model, the ubiquitous promotor CAG leads to a strong expression at all stages of 
differentiation. For future applications a more reliable system for transgene integration would be 
beneficial as the AAVS1 locus has been described as a safe harbor integration site, whose disruption 
is not associated with a disease phenotype (Oceguera-Yanez et al., 2016). A more efficient 
CRISPR/Cas9 system targeting the same locus has successfully been used by other members of our 
working group in the meantime and showed reliable locus integration (Schoger, unpublished). It 
remains unclear however, whether expression from single copy integration would be sufficient to 
measure redox sensor signals.  
A previous study made use of lentiviral transduction for the expression of redox sensors in 
cardiomyocytes (Heta, 2017; Trautsch et al., 2019). This is a fast and reliable protocol for stable in-
vitro transgene expression and was also used in this study to corroborate findings from transgenic 
HES lines. The need for constant virus production and cell transduction makes this approach tedious 
when considering constant cell requirements for large scale experiments. In addition, low 
transduction efficiency, varying viral titers and differing expression levels due to multiple infections 
of the same cell can all influence reproducibility and reliability of data. Furthermore, when 
considering tissue engineering approaches, the need for large numbers of cells with homogenous 
sensor expression becomes even more apparent. Nevertheless, we utilized lentiviral particles to 
express Grx1-roGFP2 and mito-Grx1-roGFP2 in stem cell derived cardiomyocytes and fibroblasts as a 
fast approach to test the toxicity of redox sensor expression in already differentiated 
cardiomyocytes.  
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6.2. Cardiac differentiation is deficient in transgenic HES lines 
One major concern with fluorescent redox sensors is that by overexpressing a protein containing 
reactive cysteines, cellular redox homeostasis can be changed. The redox sensor itself might act as a 
buffering system for ROS and thus influence cellular signaling. ROS signaling has been implicated in 
stem cell maintenance and function (Bigarella et al., 2014). In general, fast cycling stem cells rely on 
glycolysis and pentose phosphate pathway to fulfill their metabolic demands. As oxidative 
phosphorylation is suppressed, the amount of generated ROS by metabolic processes is very low and 
the cellular milieu reduced, as determined by analysis of total protein oxidative modification 
(Prigione 2010). In fact, it has been postulated that an activation of oxidative phosphorylation in 
pluripotent stem cells can lead to a loss of stemness by increasing ROS (Bigarella et al., 2014). It has 
been shown that mitochondrial maturation with increasing oxidative phosphorylation occurs very 
early in differentiation, together with an increase in ROS production (Cho et al., 2006; Mandal et al., 
2011). Mitochondrial maturation as observed by network formation occurs even before pluripotency 
marker expression decreases (Mandal et al., 2011). Conversly, blocking oxidative phosphorylation by 
ectopic expression of uncoupling protein 2 decreases ROS formation during differentiation and 
reduces overall differentiation capacity (Zhang et al., 2011). We did not observe a decline in stem 
cell marker expression in our transgenic lines during culture time, on the contrary, we observed high 
and robust pluripotency marker expression. Therefore, constitutive redox sensor overexpression 
might lead to a buffering of ROS signals important for differentiation initiation, which causes a 
stabilization of pluripotency and blocks differentiation. 
Despite various studies, the exact effects of ROS on cardiac differentiation remain unclear. A number 
of studies support the notion that an increase in cellular ROS will enhance cardiac differentiation. In 
undirected, spontaneous differentiation approaches utilizing embryoid bodies, application of H2O2 or 
ROS generator menadione was shown to enhance the emergence of beating areas, whereas ROS 
scavengers such as N-acetylcysteine or vitamin E derivate Trolox appeared to inhibit cardiac 
differentiation (Sauer et al., 2000). H2O2 was also able to induce cardiac differentiation and 
maturation in isolated murine embryonic cardiomyocytes in a NOX dependent mechanism (Buggisch 
et al., 2007). A number of studies attributed the cardiogenic effect observed with different 
compounds to cellular ROS increase. It was shown that Cardiothrophin-1 increased ROS in mouse 
embryonic stem cell derived embryoid bodies which led to the activation of NF-kappaB signaling 
cascades (Sauer et al., 2004). General antioxidant treatment with vitamin E or specific NOX inhibition 
abrogated this effect (Sauer et al., 2004). A similar mechanism was reported for icariin induced 
cardiomyogenesis, which could also be inhibited by administration of NOX inhibitors or Trolox (Ding 
et al., 2008). Icariin was further shown to induce NOX4 expression and p38 mitogen activated kinase 
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driven nuclear translocation of cardiac transcription factor myocyte enhancer factor 2C (Ding et al., 
2008). Another study observed an increase in cellular ROS by treatment of cells with a peroxisome 
proliferator-activated receptor α agonist that also induced cardiac differentiation. Also in this model, 
the cardioinstructive effect could be inhibited by treatment with NOX inhibitors or general 
antioxidants (Sharifpanah et al., 2008). While all these studies argue for an important role of NOX 
derived ROS in cardiac differentiation, others have shown that antioxidant treatments can also 
increase cardiomyocyte yield. An early screening study found that ascorbic acid will enhance cardiac 
differentiation while N-acetylcysteine or vitamin E are without effect (Takahashi et al., 2003). Others 
have shown that the embryotoxic compound valproic acid will increase ROS in an embryoid body 
model while reducing cardiac differentiation efficiency (Na et al., 2003). Vitamin E was able to rescue 
this effect by reducing the observed increase in ROS (Na et al., 2003). In a model of peroxisome 
proliferator-activated receptor γ coactivator 1α knock down, which led to a decrease in cellular 
mitochondrial content, ROS level was decreased while cardiomyocytes showed an improved Ca2+ 
transient amplitude that indicated a more mature phenotype (Birket et al., 2013). Treatment with N-
acetylcysteine or incubation at lower oxygen concentrations induced a similar effect. Taking these 
results into account, it becomes evident that the role of ROS in cardiac differentiation is not easy to 
pinpoint. Results will depend on the model studied and the protocol used for differentiation. As 
most studies use undefined, spontaneous differentiation protocols that utilize high serum media, it 
is unclear what other compounds might influence cardiac differentiation efficiency. Furthermore, 
these protocols yield only very small percentages of cardiomyocytes, sometimes below 10% of all 
cells. Considering the cell type specificity of redox milieus that we report in this study, it is 
questionable how informative redox measurements with typically used dye based systems of these 
mixed differentiations can be in respect to the redox milieu of the small subset of cells committed to 
a cardiac fate. In order to fully understand how ROS act in cardiac differentiation, studies of single 
ROS species in defined, highly efficient differentiation protocols are needed. A recent study 
underlines the need for more targeted analysis of ROS in cardiac differentiation (Tu et al., 2018). 
Thiol-containing antioxidants β-mercaptoethanol and monothiolglycerol were shown to reduce 
cardiac differentiation efficiency in spontaneous embryoid body differentiation, while vitamin E 
derivate Trolox enhanced cardiomyocyte numbers. All compounds were able to reduce cellular ROS, 
but only Trolox treatment led to a decrease in mitochondrial superoxide. Interestingly, β-
mercaptoethanol and monothiolglycerol even enhanced mitochondria superoxide production (Tu et 
al., 2018). This indicates that general levels of ROS are not a reliable read-out when analyzing the 
redox effects of any given treatment. It is rather necessary to investigate the individual ROS in 
defined cell populations or even compartments within cells in order to gain insight in the redox 
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regulation of cardiac differentiation. With redox sensor transgenic stem cells we possess the ability 
to analyze redox milieus in differentiating cells under such conditions in a dynamic, compartment 
specific manner. The observation of disturbed sarcomerogenesis in transgenic cardiomyocytes is in 
line with a ROS buffering effect by the sensor and the role of ROS in cardiomyocyte differentiation 
and maturation. Thus it appears that constitutive expression of redox sensors has an impact on cell 
fate.  
Should the contractile phenotype of transgenic lines observed in this study be caused by the 
constitutive expression of redox sensors, it will be very early stages of differentiation that are 
influenced, as several cardiomyocyte specific models of redox sensor expression have been 
reported. In line with this we did not observe impaired cardiomyocyte function after lentiviral 
transduction with Grx1-roGFP2 or mito-Grx1-roGFP2 of differentiated cells. Similarly, in animal 
models using adenoviral overexpression no disturbances were observed (Dey et al., 2018; Steinhorn 
et al., 2017). In addition, a mouse model with expression of Grx1-roGFP2 and mito-Grx1-roGFP2 
under the control of the cardiac αMHC promotor did not show any cardiac phenotype after 
transgene integration (Swain et al., 2016). Cells committed to a cardiomyocyte fate thus seem to be 
insensitive to redox sensor overexpression. Further experiments would be needed to clarify at which 
step differentiation is impaired in transgenic sensor cardiomyocytes. In addition, technical reasons 
for the failure of cardiac differentiation cannot be excluded. We selected only a single clone of each 
line to undergo further characterization and differentiation, which may have resulted in a selection 
bias for cells with unknown genetic or epigenetic mutations hindering cardiomyocyte function. It 
seems however unlikely that this occurred in all four analyzed lines (HES2 cyto#3, mito3#34, 
HyPer#5 and HyPerDAO#5), but screenings of other clones might lead to clarity in this case. For 
mito-Grx1-roGFP2 we were able to obtain beating cells in two out of twelve differentiations, 
indicating that also further optimization of the differentiation protocol, e.g. by ROS modulation, 
might be needed, as differentiation of these cells is in principle possible. 
6.3. The GSH/GSSG redox balance in cardiomyocyte mitochondria  
We investigated the GSH/GSSG redox milieu in cytosol and mitochondria in stem cells and stem cell 
derived cardiomyocytes. Based on previous studies (Heta, 2017; Swain et al., 2016), 100 µM H2O2 
and 1 mM DTT were used for maximum oxidation and reduction in preliminary TSA experiments. As 
cytosolic Grx1-roGFP2 appeared insensitive to DTT treatment, we increased the maximum DTT 
concentration used to 10 mM for subsequent HES and cardiomyocyte experiments. Using such high 
amounts allowed us to confidently determine the minimum reduced ratio in undifferentiated stem 
cells and cardiomyocytes as necessary for redox potential calculation. Concomittantly, we increased 
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H2O2 maximum concentration to 300 µM for HES2 measurements and to 1 mM in cardiomyocyte 
measurements. Interestingly, cardiomyocytes appeared to be already maximally oxidized when 
treated with 100 µM H2O2, in line with previous studies (Heta, 2017). Undifferentiated stem cells 
however reported an increased oxidation when treated with 300 µM H2O2 compared to 100 µM 
H2O2. This indicates a need for careful titration of compound concentration for each cell type 
analyzed in order to achieve maximum oxidation and reduction. In order to further confirm that 
maximal oxidation is reached, treatment with the thiol oxidant diamide can be performed. By 
directly oxidizing cysteine thiol residues, diamide does not act via the GSH/GSSH relay for oxidation 
of Grx1-roGFP2. Therefore, influences of the GSH/GSSG system on sensor readout are excluded. In a 
previous study, we did not observe major differences between the maximum oxidized ratio that 
could be achieved by H2O2 treatment in comparison to diamide (Heta, 2017). Although the 
concentrations in this study are in line with published results, they represent supraphysiological 
concentrations. The intracellular concentration of H2O2 is estimated to be in the range of 10 nm to 
100 nm in physiological signaling and increase up to 1 µM in acute oxidative stress (Sies, 2017). 
Measurements of extracellular H2O2 concentration have shown that a 100-fold higher oxidant 
concentration can be found in the extracellular space (Sies, 2017). This high oxidant gradient might 
explain why such high concentrations of extracellular applied oxidants are needed to achieve robust 
oxidation of intracellular redox sensor probes.  
One main finding of this study was that stem cell as well as cardiomyocyte mitochondria where 
highly oxidized in comparison to cytosol. Interestingly, adult mouse cardiomyocytes were shown to 
maintain a more reduced mitochondria redox milieu in comparison to cytosol (Swain et al., 2016), 
while the developing zebrafish heart had previously been described to have more oxidized 
mitochondria (Panieri et al., 2017). Since mitochondrial ROS are tightly linked to metabolic 
homeostasis, mitochondrial redox milieu might play a pivotal role in cardiomyocyte metabolic 
maturation. Stem cell derived cardiomyocytes have been described to have a fetal metabolic 
phenotype with a strong reliance on glycolysis, while it is known for the adult heart to rely on fatty 
acid oxidation and oxidative phosphorylation to cover the high energy demand of working 
myocardium. Modulation of the mPTP and thus mitochondria Δψ by administration of 
cyclosporine A was demonstrated to enhance cardiomyocyte differentiation (Cho et al., 2014). The 
rationale behind these findings argues that an increase in Δψ will lead to mitochondria maturation 
and increased oxidative phosphorylation, which favors cardiomyogenesis. A study using engineered 
tissues found that supplementation of medium with fatty acids and reduction of glucose content can 
indeed increase cardiac maturation in a 3D model, which is accompanied by an increase in 
mitochondrial biogenesis and oxidative phosphorylation (Mills et al., 2017). This metabolic 
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maturation occurred together with an arrest in cell proliferation induced by DNA damage response 
pathways. These findings recapitulate the in-vivo adaptations that occur after birth, when the 
mammalian heart switches from glycolytic to oxidative energy metabolism in conjunction with a 
sharp decrease in cardiac proliferation capacity (Girard et al., 1992; Mills et al., 2017). These studies 
offer insight in the intriguing link between mitochondria function and cellular fate, which is 
mediated by metabolic adaptations and potentially ROS. Redox sensor expressing cells might prove 
to be valuable tools in the investigation of metabolic and mitochondria regulation of cellular 
processes such as maturation, proliferation and regeneration. As a first step towards a deeper 
understanding of redox homeostasis in stem cells and cardiomyocytes it would be of great benefit to 
analyze stem cell derived cardiomyocytes in models of enhanced maturation such as the EHM. 
Within this thesis, proof-of-concept for redox imaging in EHM was demonstrated. It would be 
anticipated that culture of stem cell derived cardiomyocytes in EHM, which is known to enhance 
cardiac maturation, would also impact metabolic homeostasis and cellular and mitochondria redox 
milieu. Concomitant analysis of metabolic phenotype together with redox imaging at different stages 
of tissue maturation would be highly informative as to how maturation, metabolism and ROS are 
interlinked in human cardiomoycytes.  
When comparing the results of the present study, i.e., the more oxidized mitochondria milieu in 
stem cell derived cardiomyocytes, to those made in studies using transgenic mice, i.e., a more 
reduced mitochondria milieu, species differences should not be disregarded. The mouse heart is 
characterized by a much faster heartbeat than the human with around 800 bpm. Such a fast 
heartbeat will undoubtedly lead to a very high energy demand in mouse cardiomyocytes, possibly 
exceeding the demand experienced by a human cardiomyocyte. Therefore, mouse cardiac 
mitochondria might have additional adaptations that allow for an enhanced energy production 
without an increase in ROS production, one of which could be the maintenance of a more reduced 
GSH/GSSG pool. To elucidate whether species differences underlie the observed difference in 
mitochondrial redox milieu, studies of fetal and neonatal mouse cardiomyocytes would be needed. 
By comparison of these immature cardiomyocytes to adult, mature mouse cardiomyocytes the 
influence of cardiac maturation on mitochondria GSH/GSSG redox homeostasis could be further 
investigated. If cardiac maturation is accompanied by a decrease in mitochondria redox potential, 
metabolic and mitochondria maturation present as key driver mechanisms of cardiac redox 
homeostasis. A recapitulation of these results in human stem-cell based models of cardiac 
maturation would be anticipated.  
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6.4. Cardiac redox homeostasis and fibroblasts 
In the heart, fibroblast activation upon injury mediates the necessary scarring for mechanical 
stability, but excess activation of fibroblasts leads to excessive pathological fibrosis. Pathological 
fibrosis is characterized by the remodeling and deposition of extracellular matrix proteins and 
fibroblast proliferation. It leads to an increased stiffness of heart muscle, which impairs contraction 
and relaxation. The increased mechanical stress causes cardiomyocytes to adapt and acts as an 
amplifying mechanism of cardiac dysfunction. Investigations of the determinants of fibroblasts 
activation and senescence in the heart have tried to find potential therapeutic targets in order to 
limit the fibrotic response to improve long term cardiac function. In cardiac tissue engineering, it has 
previously been described that stromal cells are required for the formation of functional engineered 
myocardium. Stromal cells provide the necessary structural extracellular matrix milieu, which is 
required by cardiomyocytes for functional maturation (Christalla et al., 2012; Naito et al., 2006). 
Fibroblasts mediate tissue consolidation already within the first 30 min of tissue formation (Schlick 
et al., 2018). Fibroblast origin as well as age have an impact on engineered cardiac tissue 
development and function (Li et al., 2017; Schlick, 2019). Engineered heart muscle models have also 
elucidated how fibroblast dysfunctions can lead to cardiac disease, for example upon loss of collagen 
processing protein heat shock protein 47, leading to failure of EHM formation (Sur, 2016). 
Considering the importance of fibroblast biology for cardiac homeostasis, we extended our study to 
include analysis of human dermal fibroblast redox properties by lentiviral transduction with Grx1-
roGFP2 and mito-Grx1-roGFP2. While redox regulation of cardiomyocyte homeostasis has been 
widely studied, extensive analysis of fibroblast redox properties are missing. It has been shown that 
transforming growth factor β-1 (TGFβ-1) stimulation increases collagen production through a 
mechanism dependent on cellular ROS production by NOX4. When NOX4 is inhibited or knocked 
down by short hairpin RNA, the effect of TGFβ-1 on collagen production is reduced (Hotta et al., 
2018). In addition, fibroblast activation and increased collagen secretion by Ang 2 stimulation has 
been shown to be dependent on NOX derived ROS (Shen et al., 2006). The regulation of fibroblast to 
myofibroblast transition is therefore very likely also redox mediated. As the dermal fibroblasts 
utilized in this study are highly proliferative, they would represent a more myofibroblast-like 
phenotype. When analyzing the cellular redox milieu, in contrast to cardiomyocytes or stem cells, 
dermal fibroblasts did not show a difference in redox homeostasis between cytosol and 
mitochondria. This difference underlines the importance of cell type specific studies of cellular redox 
signaling, as it hints towards a differential regulation of GSH/GSSG homeostasis in cardiomyocytes 
and fibroblasts. Future studies of fibroblast redox homeostasis might utilize engineered tissue 
approaches, as these resemble the in-vivo environment of fibroblasts more closely than traditional 
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2D cultures on stiff matrices. Unpublished data from our lab suggest a reversal of culture induced 
fibroblast activation in 3D engineered connective tissues (Santos, unpublished). Furthermore, EHM 
offer the unique possibility to analyze the interplay between different cell types in cardiac 
development and function. By using either fibroblasts or cardiomyocytes expressing redox sensors to 
construct EHM, cell type specific redox responses to different physiological and pathophysiological 
stimuli could be elucidated without neglecting the cellular interactions that are also found in-vivo.  
6.5. Cell type targeted manipulation of ROS production 
Grx1-roGFP2 based sensors detect changes in the cellular main ROS buffering GSH/GSSG system and 
are therefore limited in their ability to display small signaling events that are characterized by fast 
and local production and degradation of ROS. In order to extend the scope of the thesis, the 
applicability of H2O2 sensor HyPer was tested in-vitro. In TSA cells, HyPer reacted to extracellular 
stimulation with concentrations above 10 µM H2O2 with an increase in fluorescence ratio. Studies 
with purified HyPer protein determined the sensitivity threshold for detection to be 25 nM H2O2, 
which is several orders of magnitude smaller than the values observed in this study (Belousov et al., 
2006). Effects of cellular H2O2 clearance and membrane permeability might however reduce the 
actual concentration of H2O2 achieved inside the cell. As observed with Grx1-roGFP2 expression in 
TSA cells, these cells are highly reduced at baseline and might therefore possess a high buffering 
capacity. As HyPer is most likely reduced by cellular GSH (Zheng et al., 1998), a highly reduced GSH 
pool will also lead to a reduced HyPer pool, that might be insensitive to small amounts of H2O2.  
Besides the ability to observe and quantify cellular H2O2 production, a sensor-producer hybrid was 
developed to manipulate intracellular ROS levels. The D-amino acid oxidase domain of HyPerDAO 
oxidizes D-amino acids under the concomitant production of H2O2. Initial studies determined the 
amount of produced H2O2 to be in the range of up to 50 - 100 nM (Matlashov et al., 2014). It stands 
to reason that this approach will lead to different cellular signaling events than simple bolus 
stimulation by extracellular addition of H2O2 to the culture medium, as the aforementioned effects 
of H2O2 neutralization by medium components will not come into play. Furthermore, by constant 
supply of D-amino acids, a constant production of H2O2 can be achieved. This in in contrast to the 
short half-life of externally added H2O2 that will quickly degrade in aqueous solutions. By using 
HyPerDAO transgenic cells for engineered tissue construction, H2O2 production in only a subset of 
the used cells can be achieved. That way, cell type specific tissue responses can be analyzed.  
Within this study transgenic HES lines expressing HyPer and HyPerDAO were generated. These lines 
were similarly dysfunctional when differentiated to cardiomyocytes as observed for the Grx1-roGFP2 
models. We therefore decided to not continue with experiments in these lines, but to generate 
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transgenic iPSC lines by a CRISPR integration approach that is still ongoing work. Previous experience 
in our lab has shown that this approach leads to improved targeting of the AAVS1 locus with high 
efficiency (Schoger, unpublished).  
6.6. Applicability and use of fluorescent redox sensors in redox research 
In this thesis we provide proof-of-concept for the genetic integration and expression of different 
fluorescent redox sensor systems in human embryonic stem cells and their differentiated 
derivatives. While fluorescent protein redox sensors offer many advances over dye based 
approaches, one of them being the ability to dynamically report redox milieu changes, they are 
certainly still limited in their applicability. While the expression of exogenous sequences is becoming 
more and more straightforward in different models, some cell types will remain difficult to transfect. 
The generation of transgenic models is not possible for all research questions and also viral vector 
mediated expression is limited. Therefore, dye based systems for ROS detection will remain a 
valuable tool in redox research, as they offer fast read-out and seemingly easy application. It is 
however crucial for all ROS detection methods that data analysis is carried out carefully bearing 
possible confounding factors in mind.  
A common feature of the discussed methods is that they report a mere observation. Determination 
of the H2O2 production rate or GSH/GSSG status of a cell or compartment is just one data point 
among many that are necessary to elucidate the effect of redox signaling on cellular processes. 
Determining changes in cellular redox homeostasis upon certain treatments or interventions is 
certainly a valid strategy, but more mechanistic approaches are needed to explain the observed 
alterations. In this respect techniques such as redox proteomics will serve in identifying possible 
effector or target proteins. The rise of easy genome editing methodologies like CRISPR/Cas9 
mediated mutation or knock out will facilitate the confirmation of targets by generation of “redox-
dead” mutant protein sequences lacking redox active cysteines.  
In respect to redox signaling and its role in the heart, this study can only serve as a primer, 
highlighting the importance of cell type and compartment specific analysis of individual ROS species. 
Especially in respect to the interplay of cardiomyocyte metabolism, maturation and redox 
homeostasis, we now have the necessary tools available to investigate these processes in a human 
system. The application of redox sensors in EHM will further enhance our understanding of cardiac 
redox regulation.   
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 Summary & Outlook 7.
ROS play an important role in the regulation of cellular fate and function. In cardiomyocytes, ROS are 
involved in processes such as differentiation, excitation-contraction coupling, hypertrophy and 
metabolism. In order to understand how redox signals regulate all these processes, suitable methods 
for the detection of ROS are necessary. Genetically encoded fluorescent protein redox sensors 
enable dynamic measurements of specific ROS and can easily be targeted to cellular compartments. 
Here, we made use of GSH sensor Grx1-roGFP2 targeted to cytosol and mitochondria, and H2O2 
sensor HyPer in TSA, HES2, stem cell derived cardiomyocytes and dermal fibroblasts. While genetic 
integration in HES2 enabled the analysis of stem cell GSH/GSSG dynamics, cardiomyocytes 
differentiated from these lines were functionally deficient. An analysis of more clonal lines and 
generation of a more targeted integration by CRISPR/Cas9 might clarify reasons for this phenotype.  
Toxicity of redox sensor expression for cardiomyocyte function could be excluded based on 
experiments performed with lentiviral transduced cardiomyocytes which retained beating. One 
major finding from analysis of these cells was the more oxidized mitochondrial milieu in comparison 
to cytosol that was observed in stem cells and cardiomyocytes. As it is known for adult mouse 
cardiomyocytes to retain a more reduced mitochondrial milieu (Swain et al., 2016), further studies 
might focus on the role of metabolic maturation and its interplay with redox biology in 
cardiomyocytes. Furthermore, Grx1-roGFP2 and mito-Grx1-roGFP2 cardiomyocytes will be valuable 
tools for the analysis of physiological and pathophysiological redox reactions towards neurohumoral, 
electrical and pharmacological stimulation. Also the application of ischemia-reperfusion models in 
cells and EHM as a well understood redox mediated damage mechanism will further increase our 
understanding of cardiomyocyte redox biology. 
In contrast to cardiomyocytes, dermal fibroblasts did not report differences in cytosolic vs 
mitochondria GSH/GSSG balance, indicating a very different cellular regulation of ROS levels. Once 
again, these findings indicate the need for cell type specific analysis of ROS. Especially in the context 
of engineered tissues such as EHM, the cell type specific GSH/GSSG balance is of high interest.  
Besides analyzing the H2O2 levels in TSA cells with HyPer, we also generated cells with expression of 
sensor-producer hybrid HyPerDAO, which allows for the targeted production of H2O2 inside the cell. 
This offers interesting possibilities of ROS manipulation in a cell and tissue context. Future work will 
focus on the generation of stable HyPer and HyPerDAO expression in iPSCs and elucidate cell type 
specific effects and pathologies in an EHM model.  
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In conclusion, the models established and described in this study will allow for a multitude of future 
studies elucidating the role of ROS in cardiac physiology and disease. In combination with tissue 
engineering, they enable us to investigate cell type specific redox responses in a human system in a 
physiological setting. 
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 Appendix 9.
9.1. List of antibodies 
Table 6 List of all antibodies used for flow cytometry (FC), immunofluorescence (IF) and Western blot (WB). ms:mouse, 
rb: rabbit, hm: human. 



















α-actinin ms Sigma A7811 1:4000 1:1000 - 
α-tubulin ms Sigma T5168 - - 1:2000 
eGFP Tag rb 
Thermo 
Fisher 














560329 1:50 - - 
total OxPhos antibody 
cocktail 

















anti-mouse Alexa-546 goat 
Thermo 
Fisher 
A-11003 1:1000 1:1000 - 
anti-mouse Alexa-633 goat 
Thermo 
Fisher 
A-21052 1:1000 1:1000 - 
anti-rabbit Alexa-546 goat 
Thermo 
Fisher 
A-11010 1:1000 1:1000 - 
anit-rabbit Alexa-633 goat 
Thermo 
Fisher 
A-21071 1:1000 1:1000 - 
anti-mouse-HRP goat Dako P0260 - - 1:10000 
anti-rabbit-HRP goat Dako P0448 - - 1:5000 
d
ye
s Hoechst 33342 - 
Thermo 
Fisher 
H3570 1:1000 1:1000 - 





S34859 1:1000 - - 
 
9.2. List of primers 
Table 7 List of all primers used for cloning and genotyping. Tm: melting temperature in °C 
primer sequence (5' -> 3') Tm purpose 
AgeI_Grx1-roGFP2_fw 
ACA CCG GTA TGG CTC AAG 
AGT TTG TGA AC 
62 
amplification of Grx1-roGFP2 cds, 






amplification of Grx1-roGFP2 cds, 






amplification of Grx1-roGFP2 cds, 
SalI cut site 
mitoGrx1roGFP2_Sal1 ACAGTCGACTTACTTGTACAGCT 62 amplification of Grx1-roGFP2 cds, 
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amplification of HyPer-DAO and 


















amplification of HyPer cds, SbfI 
cutsite 
AAVS1-CAG  TCTAGAGCCTCTGCTAACCATG 62 
sequencing of pAAVS1 donor 
vectors 
BGH in 3-1 rev TGACACCTACTCAGACAATG 56 
sequencing of pAAVS1 donor 
vectors 
pAAVS1_EF1_rv AAGGAGAGATGCGAGCCCCT 62 
sequencing of pAAVS1 donor 
vectors 
Grx1-roGFP2_fw TGC AAA ATC CAG CCT GGG AA 58 
colony PCR, sequencing of pAAVS1 
donor vectors 
Grx1-roGFP2_rv CAC GAA CTC CAG CAG GAC 58 
colony PCR, sequencing of pAAVS1 
donor vectors 
mito-Grx1-roGFP2_fw CTC AGG TCA GCA AGC GCA 58 





















66 MCS generation, colony PCR 
mutEF1_fw AGATCTgcggccgcaaggat 62 
mutagenesis PCR for puro 
correction 
mutEf1_rv GTGGCGTCTAGCGTAGGC 60 
mutagenesis PCR for puro 
correction 
mutPuro_fw GGCCCTatgaccgagtacaa 60 






mutagenesis PCR for puro 
correction 
overlap EF1rv_puro 
TTG TAC TCG GTC ATA GGG 
CCG TGG CGT CTA GCG TAG GC 
82 
mutagenesis PCR for puro 
correction 
overlap EF1_purofw 
GCC TAC GCT AGA CGC CAC 
GGC CCT ATG ACC GAG TAC AA 
82 
mutagenesis PCR for puro 
correction 
gen_Grx1-roGFP2_fw GCCCGACAACCACTACCTGAG 62 genotyping PCR 
gen_Grx1-roGFP2_rv CTGGCAACTAGAAGGCACAGTC 62 genotyping PCR 
gen_mito-Grx1-
roGFP2_fw 
CTCAGGTCAGCAAGCGCA 60 genotyping PCR 
gen_mito-Grx1-
roGFP2_rv 
TAAAGACTCGAGGCACCGTT 60 genotyping PCR 
gen_HyPer_fw GGTTTATCGTCCTGGCTCACC 61 genotyping PCR 
gen_Hyper_rv CTAGAGAGCCCGATGACTCCG 61 genotyping PCR 
gen_HyPer-DAO_fw CATAACGTTGGCCTGAGACCC 61 genotyping PCR 
gen_HyPer-DAO_rv CTGGCAACTAGAAGGCACAGTC 61 genotyping PCR 
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AAVS1_fw GCC CAC TGT TTC CCC TTC 58 genotyping PCR, wildtype locus 
AAVS1_rv CCAAAAGGTCAGCCTGGTAG 60 genotyping PCR, wildtype locus 
AAVS1_LUKI_L_F1 CCGGACCACTTTGAGCTCTA 63 genotyping PCR, locus insertion 
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9.3. Plasmid maps 
 
Figure 18 pAAVS1-CAG-GFP-puro, 10045 bp 
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Figure 19 pAAVS1-CAG-EF1-frameshiftpuro, 9596 bp 
 
Figure 20 pAAVS1-CAG-MCS-EF1-puro, 9262 bp 
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Figure 21 pAAVS1-Grx1-roGFP2, 10383 bp 
 
Figure 22 pAAVS1-mito-Grx1-roGFP2, 10596 bp  
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Figure 23 pAAVS1-HyPer, 10700 bp 
 
Figure 24 pAAVS1-HyPerDAO, 11784 bp 
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Figure 25 pGIPZ-mito-Grx1-roGFP2, 12270 bp 
 
